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ABSTRACT
Luminescent quantum dots have attracted great interest in recent years among
biological researchers since they provide solutions to problems associated with use of
organic fluorophores in cellular studies. Quantum dots show high photostability, high
emission quantum yield, narrow and symmetric emission peaks and size-dependent
wavelength tunability. The objective of my PhD studies was to develop CdSe/ZnS
quantum dot-based probes and utilize them in cellular assays.
The first phase of the work was to develop luminescent quantum dot fluorescence
resonance energy transfer (FRET) based probes for protease activity. The probes were
based on FRET interactions between quantum dots that serve as donors and rhodamine
molecular acceptors that were immobilized to the surface of the quantum dots through
peptide linkers, which contained selective enzymatic cleavage sites. Upon enzymatic
cleavage of the peptide linkers, the rhodamine molecules no longer provided an efficient
energy transfer channel to the quantum dots, which brightened the previously quenched
quantum dots. The probes were applied to detect enzyme activity, screen enzyme
inhibitors, and discriminate between normal and cancerous cells primarily because of the
difference in the proteolytic activity in extracellular matrices.
The second phase of my work was to take advantage of FRET and quantum dots to
develop pH sensor. First quantum dots were modified with metallothionein (MT) to be
water-soluble and biocompatible. The MT-coated quantum dots were labeled with
Rhodamine through the formation of amide bonds with ε-amine group of lysine in MT
peptide to form the probes. FRET efficiency between quantum dots (donor) and
rhodamine (acceptor) was pH dependent.
x

The final phase of my studies focused on the first preparation of reversible quantum
dot-based cellular probes for labile iron. The MT coated quantum dots was modified with
EDTA to form probes. When captured by the EDTA molecules, iron ions quenched the
emission of quantum dots. Removal of iron from the quantum dot surface by free EDTA
or other iron chelators with higher binding affinity resulted in a rise in the luminescence
of quantum dots. The analytical properties of the probes including sensitivity, selectivity,
and reversibility were characterized. Intracellular assays in iron-enriched astrocytes will
be carried out.

Keywords: Quantum dots; FRET; Protease sensor; pH sensor; Iron sensor; Cellular
analysis

xi

CHAPTER 1 INTRODUCTION

1.1 Objectives and aims
The main objective of my work was to develop luminescent quantum dots based
bioanalytical probes for cellular analysis, which enable simultaneous analysis of a large
number of cells and optical response to cellular signaling events in real time. Because of
the discrete electronic state of each particle, the photophysical properties of quantum dots
are sensitive to the presence and characteristics of ligands or molecules on their surface.
The newly developed quantum dots respond to changes in the cellular environment by
changing their luminescence intensity. The specific aims of my study were: i) to develop
quantum dots FRET based protease sensor for real time monitoring of Matrix
Metalloproteinases (MMPs) in cell cultures, ii) to develop quantum dots FRET based pH
sensor, and iii) to develop reversible quantum dots based sensors for labile iron in iron
rich cells.

1.2 Significance
The detection of biomolecules at the molecular level using state-of-the-art imaging
techniques has been one of the most important tasks in life sciences (1), especially the
development of high sensitivity and high specificity sensors for cancer research,
including basic tumor biology, in vivo imaging and early detection. Fluorescence methods
are the most common method of detecting biomolecules in cells. Many of the organic dye
and protein-based fluorophores suffer from serious chemical and photophysical
limitations, such as broad emission spectra, low photobleaching thresholds, and poor
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chemical stability. They are also limited in long term imaging and multicolor detection.
Further progress in the field has been realized through the development of agents that
have small size and high photostability. Luminescent quantum dots have attracted the
attention of biological researchers due to the unique electronic and optical properties.
Since water-soluble and biocompatible quantum dots were first reported in 1998(2, 3),
luminescent quantum dots have been a new promising approach to fluorescent chemical
sensing and cancer detection (4). An important goal in quantum dots research is to
develop nanoscale assemblies to continuously monitor targets in cell. My PhD project
focused on the development of quantum dots based probes for cellular analysis.

1.3 Fluorescence principle (5-6)
Luminescence is the emission of light from any substance and occurs from
electronically excited states. Based on the nature of the excited state, luminescence is
divided into fluorescence, phosphorescence and chemiluminescence. Fluorescence and
phosphorescence are similar because the excitation is formed by absorption of photos.
Fluorescence occurs when a molecule in an excited singlet state returns to the electronic
ground state by emission of a photon. Phosphorescence is the emission of light from the
triple state to the ground state. Fluorescence and phosphorescence are different because
fluorescence does not involve the change in electron spin. Chemiluminescence occurs
when the excitation is bought by a chemical reaction and excited species returns to the
ground state by light emission.
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1.3.1 Jablonski diagram
The process on light absorption and emission are usually illustrated by Jablonski
diagrams (figure 1.1). S0, S1 and S2 represent the singlet ground state, first and second
excited states respectively. T1 is the first triplet state. Usually the energy of the first
excited triplet state is lower than the energy of the corresponding singlet states.
Numerous vibration energy levels exist in each of these electronic energy levels. The
light absorbed by a molecule excites an electron from the singlet ground state, S0, to
excited states S1 or S2 according to the magnitude of the absorbed energy. This transitions
process happens in 10-14 ~ 10-15 s. The routes for the excited molecules return to its
ground state can be divided into two categories: radiative and nonradiative deactivation
process.
Fluorescence and phosphorescence are two different radiative transitions. If the
photon emission occurs from singlet excited states to ground state (S1 to S0), it is termed
fluorescence. These emission rates of fluorescence are typically108 s-1. If the photo
emission occurs from triplet excited states to ground state (T1 to S0), it is termed
phosphorescence. Transitions from triplet excited state to the ground state are forbidden
and the emission rates are slow (103-100 s-1), so phosphorescence lifetimes are typically
milliseconds to seconds. Phosphorescence is usually not seen in fluid solutions at room
temperature.
There are four significant nonradiative deactivation processes: vibrational relaxation
(VR), internal conversion (IC), intersystem crossing (IsC) and external conversion (EC).
The transition from higher vibrational energy level to lower vibrational energy level is
called vibrational relaxation. Internal conversion is the radiationless transition between
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energy states of the same spin state (e.g. S2 to S1). This process takes place 10-12 s or less.
Intersystem crossing is a radiationless transition between different spin states (e.g. S1 to
T1). The deactivation of an excited electronic state involves interaction and energy
transfer between the excited molecule and the solvent or other solutes is called external
conversion.

S2
S1

IC
IsC

VR

ABS

FL

T1
EC
PH

EC

S0
ABS - Absorbanc
FL – Fluorescence
PH - Phosphorescence

S0- ground state
S1 – Singlet first excited state
S2- Singlet second excited state
T1 - Triplet excited State

Figure 1.1 Jablonski diagram
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V.R.- Vibrational relaxation
IsC - Intersystem Crossing
I.C - Internal Conversion
E.C -Exteral conversion

1.3.2 Characteristics of fluorescence emission
Florescence always occurs from the lowest vibrational level of the first singlet excited
electronic state. Therefore, fluorescence emission spectra are generally independent of
the absorption wavelength. Fluorescence emission spectra vary widely and are dependent
upon the chemical structure of the fluorophore, pH, temperature and the solvent in which
it is dissolved. Since the same transitions are involved in both absorption and emission,
and due to the similarities of the vibrational levels of S0 and S1, the emission is the mirror
image of absorption. The energy of emission is usually less than that of absorption. Thus,
fluorescence occurs at longer wavelength. The energy difference is called the Stokes’
Shift. The Stokes’s Shifts can be caused by energy losses due to relaxation to ground
vibrational states, solvent effects, excited state reactions, complex formation, and energy
transfer. The fluorescence lifetime and quantum yield are important characteristics of a
fluorophore. The quantum yield is defined as the number of emitted photons relative to
the number of absorbed photons. The lifetime of the excited state is defined by the
average time the molecule spends in the excited state prior to return to the ground state. A
typical fluorescence lifetime is near 10 ns.

1.3.2 Fluorescence resonance energy transfer (FRET)
Fluorescence resonance energy transfer (FRET), a non-radiative energy transfer from
the excited state of a donor (D) to an acceptor (A), is the result of long-range dipoledipole interactions between the donor and acceptor (5, 7). As a result, the fluorescence
intensity and lifetime of the donor is decreased and shortened, while the acceptor
fluorescence is sensitized and its lifetime is increased. FRET donor/acceptor pairs satisfy

5

the following conditions: (i) spectral (or energy) overlap between the absorption spectrum
of the acceptor and the fluorescence emission spectrum of the donor; (ii) the donor and
acceptor molecules must be in close proximity (typically 10-100 Å). (iii) Donor and
acceptor transition dipole orientations must be approximately parallel. The rate of energy
transfer depends on the extent of spectral overlap between the emission spectrum of the
donor and the absorption spectrum of the acceptor, the relative orientation of
donor/acceptor transition dipoles and the distance between the donor and acceptor. The
rate of energy transfer is given by the equation (1).

⎛R ⎞
k t = τ D−1 ⎜ 0 ⎟
⎝ R⎠
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[1]

τD is the measured lifetime of the donor in the absence of the acceptor. R0 is termed the
critical radius of the transfer or the Forster distance, which is the distance at which the
energy transfer efficiency is 50%. The Forster distance, R0, depends on the spectral
characteristics of the donor-acceptor pair and is expressed in equation (2).
1/ 3

⎛ 3000 ⎞
⎟
R0 = ⎜
⎜ 4πN A ⎟
1/ 2 ⎠
⎝

[2]

N is Avogadro number and A 1 / 2 is the concentration of the acceptor at which the energy
transfer efficiency E is 50%. For a donor and acceptor pair that is covalently bound, the
energy transfer efficiency, E, is expressed as:
E=

R06
R06 + R 6

[3]
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The FRET efficiency can be experimentally measured by monitoring changes in the
donor or/and acceptor fluorescence intensities, or changes in the fluorescent lifetimes of
fluorophores.
FRET, incorporated with optical microscopy, is a powerful photophysical technique
because of its high sensitivity to changes in distance and relative dipole orientations
between donor and acceptor. FRET has been widely used in probing biological
phenomena, including studying protein-protein interactions (binding affinity), diffusion
dynamics, protein conformational changes, and detecting nucleic acid and peptides (812).

1.4 Quantum dots
1.4.1 Structural properties of quantum dots
Quantum dots are semiconductor nanoparticles of 1-10nm in diameter. Luminescent
nanocrystals are composed of atoms from groups II–VI (CdS, CdSe, CdTe, ZnO, ZnSe),
III–V (InP, InAs, GaN, GaP, GaAs), and IV-VI (PbS, PbSe, PbTe) of the periodic table.
Quantum dots are neither atomic nor bulk semiconductors. They are spherical, crystalline
particles of a given material consisting of hundreds to thousands of atoms. Quantum dots
are smaller than the electron-hole pairs (exciton) Bohr radius. When the size of a
semiconductor is small enough to approach the size of the materials exciton Bohr radius,
the electron energy levels can no longer be treated as a continuum. They must be treated
as discrete. This situation of discrete energy levels is called quantum confinement.
Quantum confinement leads to increased stress on the exciton, which results in increased
energy of the emitted photon. The smaller the quantum dots, the less room for exciton
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separation, and more energy is required to form the exciton. The behavior of the excited
electron can be described by a simple “particle-in-a-box” model (13). The Quantum
confinement causes a blue shift in the band gap energy (figure 1.2) and increases the
probability of overlap between the electron and hole which increases the rate of radiative
recombination. This results in quantum dots with unique optical and electric properties
(14-18). As the size of quantum decreases, the absorption onset shifts to higher energy,
indicating an increase in bandgap energy. CdX (X= S, Se, Te) quantum dots have
generated a great deal of interest due to their emission in the Ultraviolet-Visible to near
infrared (NIR) range of the electromagnetic spectrum.

Bulk crystal

Nanocrystal

Conduction band

Quantum confinement
Bandgap

Eg + E confine

Eg
Valence band

Figure 1.2 blue shift in the band gap energy in nanometer crystal compared to the bulk
crystal.
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1.4.2 Optical properties of quantum dots
In semiconductors, the electron in the valence band can be excited by photon
absorption and promoted to the conduction band, creating a “hole” in the valence band.
The excited electron will relax back to fill in the hole and emit light. This is conceptually
the same as conventional fluorescence. However, quantum dots have several optical
characteristics which distinguish them from conventional organic fluorophores because of
the strong confinement of excitons in quantum dots in such small size (quantum
confinement effect). (i) Size-tunable luminescence (2, 19); the wavelength of emitted
light is determined by the band gap energy between valence and conduction band of
quantum dots. As the size of the quantum dots decreases, the energy gap increases. Since
the band gap energy of the quantum dots is size dependent, the emission color of the
quantum dots is also size dependent. The emission peak changes from ultraviolet to
infrared by varying the size and composition of quantum dots (20, 21). (ii) Organic
fluorophores have narrow absorption. They can only be excited by a narrow range of
wavelengths. On the other hand, the absorption of quantum dots has an increased
probability at higher energies, which leads to broad absorption spectrum and enable
quantum dots to be excited by a wide range of wavelengths. Quantum dots with different
sizes can be excited with a single wavelength. This enables multiplexing or simultaneous
detection of multiple signals of quantum dots (16). Additionally, the molar extinction
coefficients of quantum dots are larger than that of organic dyes (22, 23) (iii) Quantum
dots have symmetric and narrow emission spectra without a red tail. This reduces crosstalk between emission signals (24). (iv) The long fluorescence lifetime of quantum dots
enable their use in time-gated detection to separate their signal from that of species with
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shorter lifetime species, like autofluorescence encountered in cells. This increases the
analytical sensitivity of quantum dots (25, 26). (v) A major advantage of quantum dots is
their high photostability and chemical stability compared to organic dyes, which enables
their use in imaging applications that require long exposure times (27-33).

1.4.3 Synthesis of quantum dots
The size and shape of quantum dots are controlled by altering the duration,
temperature, and ligand molecules used in their synthesis. To date, quantum dots, such as
CdSe, CdS, CdTe, have been synthesized in various media including aqueous solution
(34, 35), reverse micelles (36), polymer films (37,38), sol-gel systems (39) and
trioctylphosphine oxide (TOPO) / trioctylphosphine (TOP) (19, 40-42). High quality
quantum dots have been achieved by pyrolysis of organometallic precursors in
TOP/TOPO media, which was first reported by Murray in 1993 (19). The synthesis is
carried out by injecting dimethylcadmium (Cd(CH3)2) and sulfur, selenium, or tellurium
dissolved in TOP solution to hot TOPO media. However, dimethylcadmium is very toxic,
pyrophoric, unstable and expensive. The synthesis procedure was later refined by Peng
and coworkers who replaced the toxic cadmium precursor Cd(CH3)2 with CdO, Cd(Ac)2
and CdCO3 and lead to green synthesis (40-42). The method developed by Peng is used
extensively for the synthesis of luminescent quantum dots with some quantum dot
products already available commercially (Evident Technologies (NY), Quantum Dots
Corporation (CA)).
Confining the electrons to the bulk of luminescent quantum dots is imperative to their
bright luminescence. The excited electron or hole can be trapped by surface defects, such
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as vacancies, local lattice mismatches, dangling bonds, or adsorbates at the surfaces, and
lead to the nonradiative recombination, which will result in the low quantum yield (13).
Additionally, the uncapped quantum dots are so reactive that they readily undergo
photochemical degradation. To decrease the effect of surface defects and to protect
surface atoms from oxidation and other chemical reactions, an additional thin layer made
of a higher band gap semiconductor material, for example ZnS, is grown on the surface of
the quantum dots(43-47).

This process, often described in the literature as surface

passivation, increases the emission quantum yield, improves chemical stability and
photostablility, and reduces the toxicity by preventing leakage of Cd or Se to the
surrounding environment. Due to the availability of precursors and the simplicity of
crystallization, CdSe/ZnS core/shell quantum dots have been the most well-studied and
popular for biological applications.

1.4.4 Surface modification of quantum dots
When high quality quantum dots are synthesized in organic solvents, they are
insoluble in water, non-biocompatible and don’t have functional groups for
bioconjugation. To facilitate their application in aqueous biological systems, the
hydrophobic TOPO molecules that serve as capping ligands of luminescent quantum dots
must be replaced with bifunctional hydrophilic capping ligands or overcoated with
amphiphilic protective layer to impart water-solubility and potential bioconjugation sites.
To address this, various methods on the improvement of quantum dots biocompatibility
and stability have been developed during the past few years. These solublization
strategies can be divided into three primary categories.
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(i) Ligand exchange is a process involving the replacement of hydrophobic ligands
with bifunctional ligands in which one end that has anchoring groups can bind to the
inorganic QD surface and an opposing end imparts water solubility via hydrophilic
groups. Various ligand exchange methods were developed in recent years to form water
soluble quantum dots. Thiols (-SH) are often used as anchoring groups on the ZnS
surface. The TOPO ligands are often exchanged with thiol functionalized compounds like
mercaptoacetic acid (MAA) (3), dihydrolipoic acid (DHLA) (48), dithiothreitol
(DTT)(49), and dendrons (50). In our laboratory, we found that the amino acid cysteine
is also an effective capping ligand to create hydrophilic quantum dots (51). Weiss and
coworkers reported that cysteine containing peptides could also be used as effective
capping ligands to facilitate the water miscibility of quantum dots (52). Since the bond
between thiol and ZnS is not very strong, quantum dots will tend to aggregate over time,
the solubility of quantum dots capped with thiol chemistry is limited (53). Also the ligand
exchange processes usually disturbs the chemical and physical state of the surface atoms
of quantum dot and reduce quantum efficiency (54).
(ii) Silica encapsulation involves growth of a silica layer on the surface of quantum
dots. Also, functional organosilicone molecules are incorporated into the shell and
provide surface functionalities for bioconjugation (2, 55-58). The silica coated quantum
dots are extremely stable because the silica layer is highly cross-linked. However, the
method is very laborious and the silica layer may be hydrolyzed (59).
(iii) Another approach is to coat quantum dots with amphiphilic polymer and
phospholipids, which interleave with the hydrophobic TOPO ligands through
hydrophobic attraction and provide a hydrophilic exterior to ensure aqueous solubility

12

(33, 60-62). This process maintains the native ligands (TOPO) on the surface of quantum
dots to retain the high quantum yield of quantum dots and protect the quantum dots
surface from deterioration in biological solution. However, the final size of quantum dots
is larger, which could limit many biological applications (59).
Although several methods for solubilization of quantum dots in aqueous solution have
been devised, each has its own benefits and liability. Progress on the synthesis of high
quality water-soluble quantum dots is still playing a crucial role in the area of quantum
dots based nanobiotechnology.

1.4.5 Biological Application of quantum dots
Because of unique properties, quantum dots have been promising tools in biological
applications as an alternative to common organic fluorophores and have been a new
generation of fluorescent probes. Water soluble quantum dots are widely used in protein
assays (63-67), DNA and RNA hybridization assays (68-72), and fluorescence resonance
energy transfer (FRET) (73-77). They are also used as labels in in vitro imaging of cells
and tissues (78-82) and in in vivo imaging applications in whole animals (83-87).

1.4.5.1 Quantum dots as FRET donors
Fluorescent conventional organic molecules have been widely used as FRET donors
and acceptors because of small size, compatibility with covalent coupling, and relatively
large detectable optical signal. However, organic dyes have some problems as FRET
agents: (i) The narrow absorption spectrum leads to direct excitation of the acceptor; (ii)
The broad emission spectrum of the donor, with long tailing, overlaps with the emission
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spectrum of the acceptor and results in spectral cross-talk; (iii) Low photobleaching
thresholds prevent monitoring dynamics over long period. Quantum dots provide a
potential solution to the above problems.
Quantum dots have been investigated as FRET donors as alternatives to traditional
organic dyes because of their high photostability and their unique spectral properties (60,
88-90). (i) A broad absorption spectrum enables choosing an excitation wavelength that
does not excite the acceptor molecules directly. This prevents “bleeding” of energy into
the acceptor channel, which often increases the fluorescence intensity of the acceptor and
therefore leads to over-estimation of the FRET efficiency between the donor and acceptor
fluorophores.

(ii) A narrow and symmetric emission spectrum makes it easier to

distinguish the emission of the quantum dots from that of the acceptor and reduces the
donor spectra leakage into the acceptor channel. (iii) The size-tunable spectrum enables
control of the spectrum overlap between quantum dots and acceptor by controlling the
size of quantum dots. (iv) Multiple acceptor sites can enhance FRET efficiency.
In 1996, Kagan and his coworker first reported energy transfer between quantum dots
(91, 92). After a couple years of silence, in 2001, several research groups reported FRET
between quantum dots and organic dyes (93-95). For example, Willard and his coworker
developed quantum dots as a FRET donor in a protein-protein binding assay (93).
Quantum dots were conjugated to BAS as FRET donors and tetramethylrhodamine was
bound to the protein as the FRET acceptor. Medinta and coworkers first reported
quantum dots based self-assembled nanoscale FRET biosensors for maltose in 2003 by
coating CdSe/ZnS quantum dots capped with DHLA with maltose binding protein (MBP)
molecules (96). The FRET assay was based on the interactions between MBP and the
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acceptor molecules. Maltose molecules displaced the fluorescent acceptor molecules,
which resulted in a maltose concentration dependent increase in the emission of the MBP
coated quantum dots. Since that, quantum dots based FRET biosensor have been
interesting fields for researchers. So far, the quantum dots based FRET biosensors have
been reported to detect TNT (97), toxins (98), β-lactamase (99), collagenase(100),
DNA(101), RNA (102) and protein(103), etc.. In these probes, the quantum dots are used
as donors while the organic fluorophores serve as fluorescent acceptors. The FRET
mechanism allows the quantum dots to respond to environmental changes while avoiding
direct chemical interaction with the quantum dots that could negatively affect their photophysical properties and decrease their brightness.
Although quantum dots based FRET measurements have great potential as
biosensors, there are also a number of limitations with quantum dots for FRET. It must be
noted that the Forester theory commonly used to describe energy transfer between
molecular donor and acceptor molecules was never tested in heterogeneous systems
consisting of a luminescent nanoparticle as a donor and fluorescent molecules as
acceptors. The heterogeneity in quantum dots size can affect the precision of singlemolecule FRET measurements. From a theoretical standpoint, this process is yet to be
studied. The FRET efficiency between the luminescent nanoparticles and a fluorescent
acceptor molecule is not as high as in molecular FRET due to the larger size of quantum
dots. The presence of multiple acceptor molecules on the surface of the luminescent
quantum dots leads to a substantial accumulative effect, which is easily observed using
conventional spectroscopy and microscopy instrumentation. Quantum dots are not
optimal for FRET acceptors.
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1.4.5.2 Quantum dots in cellular studies
As previously mentioned, the objective of my PhD project is to develop quantum dot
based sensors for cellular measurements. Due to their unique spectroscopic properties,
luminescent quantum dots have been used in cellular studies. The broad excitation of
quantum dots enables simultaneous detection of different quantum dots-tagged cells with
a single excitation light source. The size dependent tunability of quantum dots facilitates
their use in an emission spectral range which minimizes the effect of cellular autofluorescence.

Most importantly, quantum dots are highly resistant to chemical and

enzymatic degradation in living cells and photobleaching, which allows for real time
monitoring of cellular dynamic events, such as cell migration, differentiation, and
metastasis (104). Since the first report of quantum dots that were used to stain F-actin in
fixed cells (2), quantum dots have been extensively used in the cell-based studies,
including cellular labeling, cellular tracking, and cellular imaging.
Cellular membrane protein and receptors, such as prostate specific membrane antigen
(PSMA) (60), mortalin (105), band 3 protein (106), Epidermal Growth Factor(EGF)
(107),

Glycine

receptors

(GlyRs)

(108),

serotonin

(109),

and

membrane

glycoprotein(110) can be labeled with quantum dots. For example, Wu and his coworker
used quantum dots coated with an amphiphilic polymer linked to immunoglobulin G and
streptavidin to localize the breast cancer marker Her2, cytoskeleton fibers, and nuclear
antigens in fixed and live cancer cells (28). They compared the brightness and
photostability of quantum dots labels to organic dyes. One of the challenges for using
quantum dots in biological studies is to label cells selectively and specifically.
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Quantum dots can be delivered into live cells by microinjection (33), electroporation
(111), peptide mediated transport (112-115), receptor mediated transport (3), and
nonspecific endocytosis (31, 32, 116). For example, Jaiswal and colleagues used quantum
dots for the long term multiple color imaging of live cells (31). Quantum dots can be
internalized by cells via nonspecific endocytosis and accumulated in vesicles in the
perinuclear region. With endosome-specific marker Pgp-EGFP, quantum dots can
undergo uptake to endosomes. The mechanism and pathway of incorporating quantum
dots into cells via endocytosis is still not very clear. However, the high photostability of
quantum dots enables long-term cell studies (i.e., up to two weeks), which can’t be
achieved with organic dyes (59).
Quantum dots have shown great potential as in vivo tumor imaging and targeting
probes. Akerman first reported peptide-coated quantum dots used to target tumor
vasculatures in mice (83). Gao and his coworker described encapsulating luminescent
quantum dots in ABC tri-block copolymers for cancer cell targeting and imaging in live
animals (60). The ABC tri-block copolymer addresses problem of aggregation and
fluorescence loss that occurred when quantum dots were in physiological buffer or inside
the live animal. Ballow and coworkers examined the in vivo behavior of injected PEGcoated quantum dots into the mouse blood stream (117). Cai and coworkers used RGD
peptide conjugated quantum dots to target giloblastoma tumor vasculate in mice. The
RGD peptide showed specific affinity for the angiogenic factor integrin αvß3, which is
upregulated in growing tumors (87). Although there are some successful reports on
quantum dots as tumor targeting and imaging probes on mouse model, more research
work is needed before quantum dots can be used as in vivo imaging in human subjects.
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The required advances include synthesis of high quality non-Cd based quantum dots,
synthesis of high-efficiency NIR emitting quantum dots, and improvement of the stability
of quantum dots in physiological buffers or inside the live animal via surface
modification (118, 119).
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CHAPTER 2 EXPERIMENTAL

This chapter describes the general experimental information, which includes
chemicals and supplies, instrumentation for characterization, and the cell culture
procedures. The specific and detailed experimental procedures will be discussed in the
appropriate chapter.

2.1 Chemicals and supplies
Cadmium oxide (CdO, Sigma), lauric acid (Sigma), trioctylphosphine (TOP, Sigma),
trioctylphophine oxide (TOPO, Sigma), hexadecylamine (HDA, Sigma), selenium
powder (Sigma), diethylzinc (Zn(Et)2, Sigma), hexamethyldisllathiane ((TMS)2S, Sigma),
chloroform (Sigma), methanol (Sigma), peptide RGDC (American Peptide Company),
dimethyl sulfoxide (DMSO, Sigma), tetramethylammonium hydroxide pentahydrate
(TAMOH, Sigma), pyridine (Sigma), Rhodamine RedTM-X, succinimidyl ester 5-isomer
(Rhodamine, Invitrogen), trypsin from porcine pancreas (trypsin, Sigma), collagenase
(Sigma), urease (Sigma), 1,10-phenantroline (Sigma), 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (Sigma), 4-Amidinophenylmethane-sulfonyl fluoride
hydrochloride (Sigma), Dulbecco’s PBS buffer solution at pH 7.4 (1X) (2.67 mM KCl,
1.47 mM KH2PO4, 137.93 mM NaCl, and 8.06 mM Na2HPO4.7H20) (Invitrogen),
HTB126 breast cancer cells (ATCC), HTB125 normal breast cells (ATCC), Dulbecco’s
modified Eagle’s medium (Invitrogen), Dulbecco’s PBS buffer (Invitrogen), Fetal bovine
serum (Invitrogen), Trypsin-EDTA (Invitrogen), L-glutamine (Invitrogen), sodium

24

pyruvate

(Invitrogen),

Epidermal

Growth

Factor(EGF,

Invitrogen),

Sodium

Bicarbonate(sigma), Bovine Insuline(invitrogen), Hybri-care cell culture media(ATCC),
trypan

blue

(invitrogen),

Metallothionein(MT,

Sigma),

Mercaptohexadecanoic

acid

Aminobenyl-EDTA(Sigma),

(MHDA,

Sigma),

Glutaraldehyde(Sigma),

Sodium cyanoborohydride(Sigma) , manganese chloride (Sigma), Calcium chloride (J.T.
Barker), ferrous ammonium sulfate (Mallinckrodt), Zinc chloride(E.M), cupric sulfate
pentahydrate (E.M), ferric chloride (Sigma), Sodium Chloride(E.M), Sodium fluoride
(E.M.), ethylenediaminetertaacetic acid disodium salt dehydrate (EDTA, J. R. Barker),
3-hydroxy-1,2-dimethyl-4(1H)-pyridone(HPO,

Sigma),

3-(N-Morpholino)

propanesulfonic acid (MOPS, USB), sodium hydroxide (sigma), hydrogen chloride acid
(sigma),

All aqueous solutions were prepared with 18 MΩ deionized water produced by a water
purification system (Barnstead Thermolyne Nanopure) and all chemicals were used as
received without further purification. Amicon Centricon YM30 spin dialysis tubes were
purchased from Microcon. Microscope glass cover slips used for microscopy and LabTek II chambered coverglass were purchased from VWR.

2.2. Characterization
2.2.1. Absorption Spectra
Absorption spectra of free quantum dots in solution and their nanoassemblies were
obtained in two systems: a Varian UV-VIS-NIR spectrophotometer system (CARY 500
Scan), and a SpectraMax M2 microplate reader (Molecular Devices, Inc.).
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2.2.2. Fluorescence Emission Spectra
Emission spectra of free quantum dots solution and their nanoassemblies were taken
in a quartz cuvette using a spectrofluorometer (PTI International, Model QM-1), or LS 55
Luminescence spectrometer (Perkin Elmer), both equipped with a 75-W continuous Xe
arc lamp as a light source.

2.2.3. Digital Fluorescence Imaging Microscopy and Spectroscopy
Emission spectra and images of free quantum dots solution and their nanoassemblies
were obtained using digital luminescence imaging microscopy and spectroscopy system,
equipped with a 100 W mercury lamp as a light source. Emission spectra were measured
by

Olympus (IX-71) inverted fluorescence microscope equipped with a 250 mm

spectrograph and a high performance 16-bit back-illuminated CCD camera (Roper
Scientific) The Roper Scientific software Win Spec/32 was used for spectral analysis.
Images were monitored by Olympus (IX-71) inverted fluorescence microscope equipped
with a high performance color CCD camera (Olympus DP 70). The software Image-pro
Plus was used for image analysis. A filter cube containing a 425 ±20 nm band-pass
excitation filter, a 465 nm dichroic mirror, and a 475nm long pass emission filter was
used to ensure spectral purity. The spectra and images were taken through 10X, 20X, and
40X objectives with numerical apertures of 0.3, 0.5, and 0.9, respectively.
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2.3. Cell culture of HTB 125 and HTB 126
2.3.1. Cell maintenance
HTB 125 is a normal breast cell line and HTB 126 is one type of breast cancer cells.
These two cell lines were used to study extracellular MMPs activity. The cells were
maintained following protocols provided by the American Type Tissue Culture
Collection (ATCC). For HTB125, the media was specially prepared by Hyclone in order
to have the same composition as the Hybri-care cell culture media used by ATCC but
without phenol red. The basic media was supplemented by adding 30 ng/mL of EGF, 1.5
g/L of Sodium Bicarbonat,e and 10% of Fetal Bovine Serum Qualified. For HTB126, 4
mM of L-glutamine, 0.01 mg/mL of Bovine Insuline, and 10% of Fetal Bovine Serum
were added to DMEM supplemented media used as growth media. The cells were grown
at 370C under 5% CO2. The medium was renewed every 3 days. Cell cultures were
planted in a 4-well chamber. The following procedures describe the cell preparation steps
of trypsinizing the cells, counting the cells, and planting the cells.

2.3.2 Trypsinization
5 mL of Trypsin-EDTA was added to the confluent 75 cm2 T-culture flask and, after a
brief washing of the cells surface, the trypsin was removed and discarded. Thus, 5 mL of
Trypsin-EDTA was added to the flask. The flask was put in the incubator (37 0C) for 1015 minutes, or until we see the cells detached from the flask surface. The trypsinized cell
suspension were homogenized with a 5 mL pipette and 1-2 mL of this cell suspension
were transferred for a new 75 cm2 T-culture flask, The cells were dispersed in 25 mL of
culture growing media and incubated at 37 0C and 5% CO2.
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2.3.3 Counting
200 μL of the cell suspension solution was mixed very well with 200 μL of trypan
blue, and then 12 μL of the mixed solution was injected into the hemacytometer. The
hemacytometer was placed under the microscope to count the number of cells. If the
number of cells counting on the hemacytometer is X, the number of the cells/mL is
20,000 times of X.

2.3.4 Planting
Cell suspension (106 cells/mL) was seeded onto a glass slide chamber. Then, 1 mL of
growth media was added to the chamber it was incubated at 37 0C under 5% CO2 for 48
hours to reach 90% confluence in order to realize a fully-developed extracellular matrix.
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CHAPTER 3 QUANTUM DOTS FRET BASED PROTEASE SENSOR

3.1 Introduction
My PhD study targets a unique family of enzymes called matrix metalloproteinases
(MMPs). MMPs are nautral proteinases that share a common modular domain structure
and are capable of degrading the extracellular matrix (ECM) components (1-3). The main
components of ECM are various glycoproteins, proteoglycans and hyaluronic acid. The
most abundant glycoproteins in the ECM are collagens. There are over 20 different
enzymes in the MMP family. Most MMPs appear to be secreted from cells in their
inactive form, making their activation a key step in regulating the amount of degradative
activity outside the cells. MMPs have the following functions: i) they regulate the level
of ECM degradation and remodelling; ii) they participate in mechanisms enabling cell
migration, wound healing, and angiogenesis; iii) they activate other MMPs; iv) they
release or activate growth factors and other bioactive molecules. The motivation to target
MMPs and develop sensors to detect their activity arises from their largely higher level in
tumors compared to normal tissues. Numerous studies have shown a correlation between
the expression of MMPs and the invasive behavior and metastasis potential of tumors (4,
5).

For example, MCF-7 breast cancer cells in culture produce both soluble and

membrane-bound factors that stimulate the production of pro-MMPs (6). A higher level
of MMP1 was found in the breast cancer cell lines MDA-MB-231 and MCF-7 compared
to normal breast cell lines (7). Clearly, it is of high importance to develop tools for the
measurement of MMPs as a mean for the detection of breast cancer cells in biopsies. A
variety of methods and probes were previously developed to detect and enable better
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understanding of the functions of MMPs in cancer development. These include the design
of biocompatible near infrared fluorochromes, novel imaging probes specific to MMPs,
fluorescent nanoparticles and fluorescence molecular tomography (FMT) (8, 9). Recently
Bremer and co-workers described a probe which is based on FRET between organic
fluorophore donor and acceptor molecules via a peptide linker that is amenable to
cleavage by MMPs (10). Here, we take advantage of quantum dots as FRET donors in
place of organic dyes and we have designed quantum dot FRET based probes to real time
monitoring of MMPs in cell cultures and effectively discriminate between MMPs activity
in normal and cancerous breast cell cultures.
As we discussed in the chapter 1, quantum dots based FRET biosensors have been
devised over the past few years. Recently, quantum dots were linked to peptide molecules
that were labeled with quenchers or molecular acceptors were used probes for proteolytic
activity (11-13). West and her coworkers first developed protease probes for collagenase
based on the FRET between quantum dots and gold nanoparticles via a proteolytically
degradable peptide linker (11). They reported a 52% rise in luminescence of quantum
dots over 47 hours of exposure to 0.2 mg/mL collagenase. The quenching mechanism is
still not clear. Possibly, the response time of these probes was long due to aggregation of
the quantum dots-gold nanocrystals clusters that do not involve peptide linking and steric
hindrances that decrease the rate of enzymatic cleavage of molecular peptides trapped
between the larger nanoparticles. Also, the use of gold as FRET acceptor will not allow
the use of ratiometric detection due to the absence of re-emission of gold nanoparticle.
Mattoussi and coworkers recently developed a modular peptide structure that allowed the
attachment of dye-labeled substrates for proteases to the surface of luminescent quantum
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dots. The researchers used these dye-labeled quantum dots in proteolytic assays that were
carried out under both excess enzyme and excess substrate conditions. The assays
provided quantitative data including enzymatic velocity, Michaelis-Menten kinetic
parameters, and mechanisms of enzymatic inhibition (12). Mattoussi and co-workers also
reported a detailed mechanistic study that aimed to understand the mechanism of
fluorescence resonance energy transfer between quantum dots and linked molecular
acceptors (13). The researchers concluded that FRET between quantum dots and linked
molecular acceptors could be described using the Forester FRET theory. It seems that due
to their nanometric dimensions, quantum dots can be described, at first approximation, as
point dipoles. Therefore, the distance between quantum dots and linked molecular
acceptors can be measured from the center of the quantum dots to the molecular
acceptors adsorbed to the quantum dot surface. It should be mentioned however, that
other factors like the shape of the quantum dots and the nature of the shell separating the
quantum dots and molecular acceptors could affect the distance dependence of the FRET
efficiency in this system. More studies are needed to fully understand the mechanism of
FRET between nanoparticle donors like quantum dots and molecular acceptors.
Here, we developed a quantum dots based FRET protease sensor with the capability
to monitor the enzyme activity in real time. In these probes, rhodamine molecules are
attached to the surface of the quantum dots and used as molecular acceptors. Quantum
dots-molecular acceptor systems are advantageous because of the simultaneous emission
increase and decrease of the emission of quantum dots and molecular acceptors, which
enables a ratiometric analysis method and results in high quantitative power. A schematic
diagram of the quantum dot FRET based protease probes is shown in scheme 3.1. To
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fabricate the quantum dots FRET based probes CdSe/ZnS quantum dots capped with trioctyl phosphine oxide (TOPO) molecule were modified by exchanging the TOPO ligands
with tetra peptide RGDC (Arginine-Glycine-Aspartic acid-Cysteine) molecules to form
water-soluble quantum dots. The peptide molecules were bound to the ZnS shell of the
CdSe/ZnS quantum dots through the thiol group of cysteine (C). The peptide-coated
quantum dots were labeled with Rhodamine Red™-X succinimidyl ester through the
formation of amide bonds with the amino terminals of the coating peptides to form the
quantum dots based FRET probes. In these FRET probes the quantum dots served as
donors and the attached rhodamine molecules as acceptors. The emission of the quantum
dots was quenched and the emission of the attached rhodamine molecules increased due
to FRET between the quantum dots and the rhodamine molecules. Upon cleavage by
enzymes the rhodamine molecules were removed from the surface of the quantum dots,
which resulted in an increase in the emission peak of the quantum dots and a
corresponding decrease in the emission of the displaced rhodamine molecules due to a
decrease in FRET efficiency between the quantum dots and rhodamine molecules. The
quantum dots based probes were first applied for detecting enzyme activity and for
screening enzyme inhibitors in solution. Then, they were also used for the measurement
of extracellular matrix metallproteinases (MMPs) activity in normal and cancerous breast
tissue. The probes were able to discriminate between normal and cancerous cells
primarily because of the difference in the proteolytic activity of their extracellular
matrices.
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Scheme 3.1 Schematic representation of quantum dots FRET based protease sensor

3.2 Experimental
3.2.1 Synthesis of TOPO coated quantum dot
TOPO capped CdSe/ZnS quantum dots were prepared following a method developed
by Peng with slight modifications (14, 15). Briefly, 12.7 mg CdO and 160 mg lauric acid
were mixed under nitrogen for half hour. The mixture was heated to >200 °C to fully
dissolve the cadmium oxide until a clear colorless solution was formed. Then, 1.94 g
TOPO and 1.94 g hexadecylamine (HDA) were added to the solution under stirring and
the temperature was increased to 280°C. Then, 80 mg selenium powder dissolved in 2ml
solution of trioctylphosphine (TOP) was rapidly injected into the solution under vigorous
stirring. The mixture was cooled to ~200 °C and kept at this temperature for 3 minutes.
Then, a 2 ml TOP solution containing 250 μl hexamethyldisilathiane ((TMS)2S) and 1 ml
diethylzinc (Zn(Et)2) was premixed well under nitrogen and gradually injected into the
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solution. The injection took about 1 minute to complete. The reaction mixture was kept
at 180°C for one hour. The solution was then cooled to room temperature and the
resulting sample of CdSe/ZnS quantum dots was washed three times with methanol and
re-dissolved in chloroform.

3.2.2 Synthesis of peptide coated quantum dots
The ligand exchange reaction used to replace the TOPO ligands with RGDC was
carried out in a mixture of pyridine and dimethyl sulfoxide following a method first
reported by Pinaud and coworkers (16). 1mL of 1µM TOPO coated CdSe/ZnS quantum
dots were precipitated with methanol and re-dissolved in 2ml 9:1(V/V) pyridine:DMSO
cosolvent. The use of this co-solvent effectively prevented aggregation of quantum dots
during the reaction. Then, 200ul 5mg/mL peptide in DMSO was added to the reaction
mixture. The pH was adjusted to 10 by adding tetra-methyl ammonium hydroxide
(TAMOH) 20% (w/v) in methanol to the reaction mixture. The TAMOH molecules were
used to form anionic cysteine thiolates to facilitate binding of the peptide to the
CdSe/ZnS quantum dots through the cysteine residues (17). The peptide coated quantum
dots were vortexed for 30 minutes, centrifuged, and re-suspended in DMSO. Then the
solution was centrifuged and redissolved in Dulbecco’s PBS buffer solution at pH 7.4.
Unbound peptide molecules were removed by two repeated cycles of spin dialysis using
an Amicon Centricon spin dialysis tube with a cutoff molecular weight of 30kDa
(Microcon YM30, Millipore Corp.).

In each spin dialysis cycle, the sample was

centrifuged at 2000 rpm for 20 minutes and washed with the Dulbecco’s PBS buffer
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solution at pH 7.4. The peptide coated quantum dots were kept at 4°C in the Dulbecco’s
PBS buffer solution at pH 7.4 until used.

3.2.3 Conjugation of Rhodamine to the peptide coated quantum dots
Rhodamine labeled peptide-coated quantum dots were prepared by adding 150 µL of
0.1 µM peptide coated quantum dots and varying volumes (0 µL to 150 µL) of 4.8 µM
Rhodamine Red™-X, succinimidyl ester to a PBS buffer solution of pH 7.4 to a final
volume of 1.5 mL. Succinimidyl ester is a good leaving group and it undergoes
nucleophilic attach by the amine group in a peptide. The reaction mixture was incubated
for 1 hour at room temperature.

3.2.4 Enzyme activity and inhibition assays of trypsin
Rhodamine-labeled peptide-coated quantum dots that were prepared in solution
containing a rhodamine:quantum dots ratio of 48:1 were used as our FRET-based
enzymatic activity probes. 500 µL of 10nM quantum dot FRET based probes and varying
volumes ranging from 0 µl to 500 µL of 1 mg/mL trypsin were added to Dulbecco’s PBS
buffer solution at pH 7.4 to a final volume 1.0 mL. Time dependent spectral
measurements were carried out following the addition of trypsin using a fluorescence
spectrometer or a digital fluorescence spectral imaging system. Inhibition assays were
performed in a chambered cover glass (LabTek) and were monitored using digital
fluorescence imaging microscopy and spectroscopy. To carry out the inhibition assay,
250 µL of 1 mg/mL trypsin were added to Dulbecco’s PBS buffer solution at pH 7.4 that
contained inhibitors of various concentrations to a total volume of 500 µL. Following 30
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minutes incubation 500µL of 10nM quantum dot FRET-based probes were added to the
mixture and FRET measurements were carried out to monitor the enzymatic reaction.

3.2.5 Enzyme activity of collageanse
500 µL of 10nM quantum dot FRET based probes and varying volumes ranging from
0 µl to 50 µL of 100 µg/mL collgenase were added to Dulbecco’s PBS buffer solution at
pH 7.4 to a final volume 1.0 mL. Time dependent spectral measurements were carried out
following the addition of collagenase using a fluorescence spectrometer.

3.2.6. Cell analysis
Qualified 106 cells/mL were seeded and cultured on glass slides for 48 hours to reach
90% confluence in order to realize a fully developed extracellular matrix. The cells were
kept at 370C under 5% CO2. The cells were washed with Dulbecco’s PBS buffer, and
then quantum dots protease probes were added and analyzed by digital fluorescence
microscopy.

3.2.7 Fluorescence Spectroscopy Measurements
Emission spectra of TOPO coated quantum dots, peptide coated quantum dots and
quantum dots-peptide-rhodamine conjugates were measured using a spectrofluorometer
(PTI International, Model QM-1), equipped with a 75-W continuous Xe arc lamp as a
light source. All samples were excited at 445 nm, which is near the minimum of the
rhodamine absorption spectrum in order to reduce interference from direct excitation of
rhodamine. Emission scans were measured from 480nm to 700nm in a 1-cm cell.
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3.2.8. Digital Fluorescence Imaging Microscopy and Spectroscopy
Emission spectra of the quantum dot FRET probes were carried out using an Olympus
(IX-71) inverted fluorescence microscope equipped with a 250 mm spectrograph and a
high performance 16-bit back illuminated CCD camera (Roper Scientific). The Roper
Scientific software Win Spec/32 was used for spectral analysis. Emission images of
quantum dots FRET probes were obtained using an Olympus (IX-71) inverted
fluorescence microscope equipped with a high performance color CCD camera (Olympus
DP 70). The software Image-pro plus was used for image. The spectra and images were
taken through 10X and 20X objectives with numerical apertures of 0.3 and 0.5,
respectively. A filter cube containing a 425 ±20 nm band-pass excitation filter, a 505 nm
dichroic mirror, and a 515-nm long pass emission filter was used.

3.3 Results and discussion
3.3.1 Peptide coated quantum dots
Peptide coated quantum dots were synthesized as described in the experimental
section. Figure 3.1a shows the emission spectra of 100nM solutions of TOPO and peptide
coated quantum dots when excited at 445 nm. It can be seen that the emission intensity of
the peptide coated quantum dots was four times lower than the emission intensity of
TOPO coated quantum dots. Normalized emission spectra of TOPO and peptide coated
quantum dots are shown in figure 3.1b. The emission spectra show negligible changes in
the peak emission wavelength and bandwidth following the ligand exchange process.
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Despite the significant reduction in emission quantum yield, which is typical to quantum
dots when dispersed in aqueous media, the quantum dots were sufficiently luminescent to
successfully prepare quantum dots based enzymatic activity probes. The ligand exchange
method that was used in our experiments to coat the quantum dots with peptide molecules
is a simple, one-step reaction that resulted in high-quality peptide coated quantum dots.
As seen in figure 3.1b the photophysical properties of the quantum dots were not affected
by the peptide coating. Additionally, the attachment of peptide molecules to the quantum
dots enabled further conjugation of rhodamine to the amino terminals of the peptides.
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Figure 3.1 a) Emission spectra and b) normalized emission spectra of TOPO coated
quantum dots (red) and peptide-coated quantum dots (black) (λex = 445 nm).
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3.3.2 Conjugation of Rhodamine to the peptide coated quantum dots
Rhodamine molecules were conjugated to the peptide coated quantum dots as
described in the experimental section.

The effect of increasing concentration of

rhodamine in the reaction mixture on the fluorescence resonance energy transfer (FRET)
efficiency of the rhodamine labeled quantum dots is shown in figure 3.2a. When excited
at 445 nm the emission spectra of the rhodamine labeled quantum dots show two clearly
separated emission peaks of the quantum dots and the rhodamine molecules at 545 nm
and 587 nm respectively.

The emission peak of the quantum dots decreases with

increasing rhodamine concentration indicating the occurrence of FRET between the
quantum dots and the rhodamine molecules. The FRET efficiency increased with
increasing rhodamine concentration and the effect leveled of at a rhodamine:quantum
dots molar ratio of 48:1. Luminescent quantum dots that were prepared under this ratio
conditions were later used as our FRET-based protease sensors. Control experiments
showed that the emission intensity of solutions of similar rhodamine concentration in the
absence of peptide coated quantum dots was 10 times lower than the intensity of the red
emission peak at 587 nm of the rhodamine labeled quantum dots (shown in figure 3.2b).
This is another indication that the large emission signal at 590 nm of quantum dotrhodamine conjugate is a result of FRET between the quantum dots and bound rhodamine
molecules.
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Figure 3.2 a) Emission spectra of rhodamine-labeled peptide-coated quantum dots at
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Figure 3.3 depicts the emission intensity of quantum dots decay percentage as a function
of the rhodamine/quantum dots ratio. Here, Fd0 is the emission intensity of quantum dots
without labeling rhodamine and Fd is the emission intensity of quantum dots in
rhodamine-labled-quantum dots conjugate. It was clearly shown that Fd/Fd0 decrease as
the increase of rhodamine/quantum dots ratio. For a 48:1 ratio of rhodamine: quantum
dots, it indicates 75% quenching of quantum dots signal compared to unlabeled quantum
dots. These results strongly suggest that FRET is the primary mechanism for the reported
observations.

1.2

c
1.0

Fd/Fdo

0.8

0.6

0.4

0.2

0

10

20

30

40

50

Ratio of rhodamine and quantum dots

Figure 3.3 The emission intensity of peptide coated quantum dots decay percentage
(Fd/Fd0) versus the ratio of rhodamine and quantum dots. Fd0 is the emission intensity of
quantum dots without labeling rhodamine and Fd is the emission intensity of quantum
dots in rhodamine-labled-quantum dots conjugate.
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FRET interactions between quantum dots and fluorescent acceptor molecules are not
fully understood. Unlike FRET between donor and acceptor molecules, the distance
between quantum dots and molecular acceptors is not well-defined. Our study shows that
the FRET efficiency is high even when a short tetra-peptide links the quantum dots and
the acceptor molecules. It is possible that the accumulative interaction between a single
quantum dot and multiple acceptor molecules compensates for the low FRET efficiency
between quantum dots and individual acceptor molecules when these are bound through a
short linker.

3.3.3 Enzyme activity measurements
The quantum dots FRET-based enzymatic probes were used to determine the activity
of the enzyme trypsin. Trypsin is a proteolytic enzyme with a molecular weight of 23,800
Daltons that cleaves proteins and peptides at the carboxyl end of lysine (K) and arginine
(R). Emission spectra showing the effect of trypsin at increasing concentration on the
emission of the quantum dot FRET probes are shown in figure 3.4a (λex = 445nm). The
spectra were recorded 15 minutes after adding trypsin to the quantum dots solution. An
increase in the quantum dots emission peak at 545 nm and a decrease in the rhodamine
emission peak at 590 nm were clearly seen indicating a significant decrease in the FRET
efficiency. Figure 3.4b describes the trypsin concentration dependence of the ratio Fd/Fa.
Fd and Fa were the peak emission intensities of the quantum dot FRET-based probes
when excited at 445 nm at 545 nm (quantum dot donors) and 590 nm (rhodamine
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acceptors) respectively. The Fd/Fa ratio was normalized to (Fd/Fa)0 which is the value of
Fd/Fa prior to the addition of trypsin to the quantum dot FRET-based solutions. The
trypsin concentration dependent FRET signal changes were attributed to the enzymatic
cleavage of the peptide molecules which led to the expected release of rhodamine
molecules from the quantum dots to the solution.
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Figure 3.4 a) Emission spectra of the quantum dot FRET-based probes at increasing
trypsin concentration: (a) 0μg/mL, (b) 25μg/mL, (c) 50μg/mL, (d) 100μg/mL, (e)
250μg/mL, (f) 500μg/mL. (λex = 445 nm). b) Trypsin concentration dependence of
Fd/Fa , 15 minutes following the addition of trypsin to solutions of quantum dot based
probes. Fd/Fa values were normalized to (Fd/Fa) 0, which is the ratio Fd/Fa prior to
adding trypsin to the quantum dot probes solutions.
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Time dependent measurements of the FRET signal at increasing trypsin levels were
carried out to demonstrate the ability of the quantum-dots based probes to provide
dynamic information over long observation times.

Figure 3.5 shows the temporal

dependence of the ratio Fd/Fa at increasing trypsin concentration ranging from 0 to 500
μg/ml (λex = 445 nm). The Fd/Fa ratio was normalized to (Fd/Fa)0 which is the value of
Fd/Fa prior to the addition of trypsin to the quantum dot FRET-based solutions. It can be
seen that the ratio Fd/Fa increased faster at higher trypsin concentrations. For a
concentration of 250 µg/ml trypsin the enzymatic reaction was completed in less than 15
minutes. As expected, the duration of the enzymatic assays increased with decreasing
enzyme concentrations. It was possible to detect as low as 0.1 µg/mL, (4 picomol), in a 2hour assay. The short assay time is a significant advantage over previously reported
FRET based quantum dot probes in which longer reaction times were reported (11).
Control experiments using solutions of quantum dots based probes in the absence of
trypsin indicated insignificant changes in the FRET signal (Fd/Fa) over several hours.
This supported our conclusion that the quantum dot FRET-based probes only responded
to the proteolytic activity of trypsin.
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Figure 3.5 Temporal dependence of the rhodamine-labeled peptide-coated quantum dots
at increasing trypsin concentration: (a) 0μg/mL, (b) 25μg/mL, (c) 50μg/mL, (d)
100μg/mL, (e) 250μg/mL, (f) 500μg/mL. The ratio Fd/Fa was normalized to (Fd/Fa)0,
which is the ratio Fd/Fa prior to adding trypsin to the quantum dot probes solutions.

Furthermore, to examine selectivity of these probes, we monitored the enzymatic
activity of urease in the quantum dots based probes. We used the enzyme urease as a
negative control to demonstrate the specificity of the quantum dots based enzyme probes.
The enzyme ability comparison between trypsin and urease under the same concentration
(50µg/mL) and under the same condition are showed in figure 3.6a (emission spectra)
and figure 3.6b (temporal dependence). As a result, with a concentration of 50ug/mL
trypsin, the emission intensity of quantum dots increases and the emission intensity of
rhodamine decreases with time, after 15mins, the Fd/Fa increase from 0.4 to 0.90. On the
other hand, with a concentration of 50ug/mL urease, the emission intensity of quantum
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dots and rhodamine hardly change over 15mins. Both of the spectra and temporal
dependence clearly demonstrated that the quantum dots based probe FRET efficiency is
affected by trypsin and is not affected by urease or in the absence of proteases
(Dulbecco’s PBS buffer solution at pH 7.4).
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Figure 3.6 (a) Emission spectra and (b) Temporal dependence of the rodamine-labeled
peptide-coated quantum dots with different enzyme: a) buffer (black), b) 50µg/mL
trypsin(red), c) 50µg/mL urease(green).
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Digital fluorescence images shown in figure 3.7 provided clear visual evidence of FRET
between the quantum dots and the attached rhodamine and of the effect of trypsin on the
FRET signal. Image 3.7a shows a digital fluorescence image of peptide coated quantum
dots with their characteristic green emission. Image 3.7b shows the fluorescence image of
the peptide coated quantum dots when labeled with rhodamine. The quantum dots emit
yellow-orange light due to FRET between the quantum dots and rhodamine molecules.
Image 3.7c shows the fluorescence image of the quantum dot FRET-based probes 15
minutes following the addition of 250 µL of 1 mg/mL trypsin. It can be seen that the
emission color of the quantum dots turned green due to enzymatic cleavage of the RGDC
peptide linker, which released rhodamine molecules to the solution and restored the green
emission color of the quantum dots. It must be noted that the rate of enzymatic cleavage
of a substrate consisting of a target peptide linking a quantum dot as a donor and a
molecular acceptor would be lower than the rate of enzymatic cleavage of a target peptide
linking between a molecular donor and a molecular acceptor. This is due to steric
hindrances in the quantum dot/molecular acceptor system. However, the application of
luminescent quantum dots as donors in FRET assays is advantageous due to the ability to
link multiple acceptors to a single quantum dot, which, in turn, leads to larger FRET
signal changes in enzymatic assays. Additionally, the high photostability of quantum dots
enables highly sensitive real-time enzymatic assay in volume-limited samples and
eventually in single cells.
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Figure 3.7 Digital fluorescence images of (a) peptide coated quantum dots showing green
emission, (b) rhodamine-labeled peptide coated quantum dots showing yellow-orange
emission due to FRET between the quantum dots and rhodamine molecules, (c) quantum
dot FRET-based probes when incubated for 15 minutes in a solution of 250μg/mL trypsin
showing green emission.

3.3.4 Screening enzyme inhibitors
To further demonstrate the utility of the quantum dots FRET-based enzymatic probes,
we measured the inhibition efficiency of the trypsin inhibitors 4-(2-aminoethyl) benzenesulfonyl

fluoride

hydrochloride,

4-amidinophenylmethane-sulfonyl

fluoride

hydrochloride and 1, 10-phenanthroline. 4-(2-Aminoethyl) benzene-sulfonyl fluoride
hydrochloride and 4-amidinophenylmethane-sulfonyl fluoride hydrochloride are watersoluble, relatively non-toxic irreversible inhibitors of serine proteases (18, 19). 1, 10phenanthroline is a reversible inhibitor of metallo-proteinases and metal activated
proteinases (20). The structures of inhibitors are shown in figure 3.8.
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Figure 3.8 Structure of 4-(2-Aminoethyl) benzene-sulfonyl fluoride hydrochloride (1), 4Amidinophenylmethane-sulfonyl fluoride hydrochloride (2) and 1,10- phenantroline (3)
used for inhibition assay.

Figure 3.9 shows the temporal dependence of the ratio Fd/Fa of quantum dot FRETbased enzymatic probes in the presence of 250µg/mL trypsin and 4-(2-Aminoethyl)
benzene-sulfonyl fluoride hydrochloride at increasing concentrations from 0 to 2.5
mg/mL. In the inhibition assays, the trypsin inhibitor was first incubated with 250 µL of 1
mg/mL trypsin for 30 minutes at room temperature. 500µL of 10nM quantum dot FRETbased probes were added to the solution and the fluorescence of the quantum dots was
monitored using digital fluorescence spectroscopy. The rate of increase of the ratio Fd/Fa
was found to be dependent on the concentration of the enzyme inhibitor. A level of 2.5
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mg/mL 4-(2-aminoethyl) benzene-sulfonyl fluoride hydrochloride led to a 75% inhibition
of trypsin activity.
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Figure 3.9 Temporal dependence of Fd/Fa in the presence of 250µg/mL trypsin and
increasing concentrations of the trypsin inhibitor 4- (2-Aminoethyl) benzene-sulfonyl
fluoride hydrochloride. a) a control experiment in the absence of trypsin and trypsin
inhibitor, b) 2.50 mg/mL, c) 1.25 mg/mL, d) 250µg/mL, e) 50µg/mL, f) 0µg/mL.

A comparison between the inhibition efficiency of 4-(2-aminoethyl) benzene-sulfonyl
fluoride hydrochloride, 4-amidinophenylmethane-sulfonyl fluoride hydrochloride and 1,
10-phenanthroline at 250 µg/mL is shown in figure 3.10, which describes the temporal
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dependence of the FRET efficiency (Fd/Fa) of the quantum dot FRET-based probes in the
presence of the tested inhibitors. It can be seen that, at this level, 1,10-phenanthroline
completely inhibits trypsin activity. It can also be seen that the inhibition efficiency of 4(2-aminoethyl) benzene-sulfonyl fluoride hydrochloride is 2.3-fold higher than the
inhibition efficiency of 4-Amidinophenylmethane-sulfonyl fluoride hydrochloride.
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Figure 3.10 Real time monitoring of the inhibition efficiency of 250μg/mL trypsin
inhibitor in the presence of 250μg/mL trypsin. a) A control experiment in the absence of
trypsin and trypsin inhibitor (■), b)1,10 phenantroline (○), c) 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (▲), d) 4-Amidinophenylmethane-sulfonyl fluoride
hydrochloride (◊) and e) in the absence of trypsin inhibitor (▼).
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Figure 3.11 show the inhibition ability of trypsin inhibitors. The inhibition ability was
calculated using equation [4].

⎡⎛ Fd
⎢⎜⎜
⎢⎝ Fa
Inhibition = ⎣
⎡⎛ Fd
⎢⎜⎜
⎢⎣⎝ Fa

⎞ ⎛ Fd ⎞ ⎤
⎟⎟ − ⎜⎜ ⎟⎟ ⎥
⎠ 0 ⎝ Fa ⎠ I ⎥⎦
⎞ ⎛ Fd ⎞ ⎤
⎟⎟ − ⎜⎜ ⎟⎟ ⎥
⎠ 0 ⎝ Fa ⎠ b ⎥⎦

[4]

(Fd/Fa)0 is the ratio of emission intensity of quantum dots and rhodamine with trypsin
(without inhibitor) after adding the quantum dots based probes for 15mins. (Fd/Fa)I is the
ratio of emission intensity of quantum dots and rhodamine with trypsin and different
concentrations of inhibitor after adding quantum dots based probes for 15mins. And,
(Fd/Fa)b is the ratio of emission intensity of quantum dots and rhodamine in Dulbecco’s
PBS buffer solution at pH 7.4 without trypsin and inhibitors. The inhibition efficiency of
4-(2-aminoethyl) benzene-sulfonyl fluoride hydrochloride is higher than that of 4amidinophenylmethane-sulfonyl fluoride hydrochloride. It is clearly seen that 1,10phenanthroline is the best performing inhibitors. With a concentration of 250µg/mL,
1,10-phenanthroline inhibits 100% of enzymatic activity of trypsin, while 4-(2aminoethyl) benzene-sulfonyl fluoride hydrochloride and 4-amidinophenylmethanesulfonyl fluoride hydrochloride inhibit trypsin by 45% and 20% respectively.
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Figure 3.11 Inhibition ability of trypsin inhibitors: a) 1,10-phenanthroline, b) 4-(2Aminoethyl) benzene-sulfonyl fluoride hydrochloride and c) 4-Amidinophenylmethanesulfonyl fluoride hydrochloride.

3.3.5 Monitoring the proteolytic activity of MMPs in normal and cancerous breast
cells
Collagenase is an extracellular matrix metalloproteinase (MMP). The quantum dots
FRET-based enzymatic activity probes were first used to determine the activity of
collagenase in solution to test the analytical capabilities of the quantum dots FRET based
probes in a model system. We hypothesized that since collagenase has a wide range of
proteolytic activity, it would be at least as effective as trypsin in cleaving the RGDC
peptide that was attached to our quantum dots. FRET measurements of the quantum dots
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at increasing levels of collagenase in solution are shown in figure 3.12. Similarly to
trypsin, the fluorescence intensity of the quantum dots at 545 nm increased while the
fluorescence intensity of the rhodamine molecules decreased due to the enzymatic
cleavage of the peptide by collagenase. It should be noted, however, that a 20-fold lower
level of collagenase compared to trypsin was needed to similarly affect the FRET signal
of the quantum dots. As mentioned previously, the higher cleavage rate by collagenase
could be attributed to its non-selective peptide cleavage activity. The temporal
dependence of the ratio Fd/Fa of the quantum dots at increasing collagenase concentration
ranging from 0 to 5µg/mL provided information on the rate of the enzymatic reaction.
The ratio Fd/Fa was collagenase concentration dependent and time dependent. With a
concentration of 5µg/mL collagnase the enzymatic reaction was completed in 15 minutes.

56

30000

(a)
a

Fluorescence Intensity

25000

d

b
c

20000

d

c

15000
b

10000

a

5000
0
480

520

560

600

640

Wavelength (nm)

1.4

(b)

d

1.2

Fd/Fa

1.0
0.8

c

0.6
b
0.4
0.2

a

0

150

300

450

600

750

900

Time (sec)

Figure 3.12 (a) Emission spectra of rhodamine labeled peptide-coated quantum dots 15
minutes following the addition of collagenase of increasing concentration. (b) Time
dependence of the ratio Fd/Fa of the rhodamine-labeled peptide-coated quantum dots at
increasing collagenase concentration. The ratio Fd/Fa was normalized to (Fd/Fa)0, which is
the ratio Fd/Fa prior to adding collagenase to the quantum dot probes solutions. a) 0μg/mL
(black), b) 0.5μg/mL (red), c) 2.5μg/mL (green), d) 5.0μg/mL (blue)
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Following the successful demonstration of using quantum dot FRET based probes to
monitor the activity of collagenase, we measured in real time the activity of MMPs in cell
cultures.

Digital fluorescence microscopy images were used to measure the FRET

between quantum dots and rhodamine and the effect of MMPs in normal and cancerous
breast cells on the FRET signal. The experiments were carried out using the cell lines
HTB 125 (normal breast cells) and HTB 126 (breast cancer cells). The cells were
maintained following protocols provided by the American Type Tissue Culture
Collection (ATCC). 106 cells/ml were seeded and cultured on glass slides for 48 hours to
reach 90% confluence in order to realize a fully developed extracellular matrix. The
quantum dot FRET probes were added to the cultures and covered with cover slips to
enable close proximity of the probes to the extracellular matrix. Figure 3.13 shows
images of the quantum dot FRET probes in normal (images a, b) and cancerous (images
c, d) breast cells when taken at t = 0 and t = 15 minutes following the addition of the
probes. It can be seen that the emission color of the quantum dots (orange) did not change
when incubated with normal breast cells. Whereas there was a significant change of
emission color from orange to green when the quantum dot probes were incubated with
breast cancer cells, which is attributed to the over expression of MMPs in breast cancer
cells. The quantum dots probes could be used to discriminate normal and cancerous
breast cells based on the different lever of MMPs expressions between normal and
cancerous breast cells.
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(a)

(b)

Figure 3.13 Digital fluorescence microscopy images of rhodamine labeled peptidecoated quantum dots in cell culture. (a) Incubated in HTB 126 cell line for 0 minute, (b)
incubated in HTB 126 cell line for 15 minutes; (c) incubated in HTB 125 cell lines for 0
minutes, (d) incubated in HTB 125 cell lines for 15minutes.

Figure 3.14 describes the temporal dependence of the FRET signal of the quantum
dot FRET probes in normal and cancerous breast cultures. Curve (a) shows the results of
a control experiment in which quantum dot FRET probes were observed in the absence of
cells. No change in the emission properties of the quantum dots was detected. Curves (b)
and (c) follow the response of the quantum dot FRET probes in normal (b) and cancerous
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(c) breast cells. It can be seen that the MMPs activity in breast cancer cultures is
significantly higher compared to normal cells. The change in FRET signal is completed
in about 10 minutes.

c

Normailzed Fd/Fa

1.8
1.6
1.4
1.2

b
a

1.0
0

3

6

9

12

15

Time (min)

Figure 3.14 Temporal dependence of FRET signal (Fd/Fa) of quantum dot FRET-based
protease sensors in the absence of cells (a) and when attached to the extracellular matrix
of normal breast cells (b) and cancerous breast cells (c).

3.4 Conclusions
We have successfully synthesized peptide coated CdSe/ZnS quantum dots. The
peptide coated quantum dots were water-soluble, biocompatible, and maintained their
original photophysical properties. We designed and developed new quantum dots based
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FRET probes in which rhodamine molecules were bound to the quantum dots through a
peptide linker that contained selective cleavage sites to proteolytic enzymes. The
quantum dots FRET-based enzymatic probes were first used to test the enzymatic activity
of trypsin in solution. The FRET signal changes were found to be trypsin concentration
dependent and time dependent. The rapid response time of the probes enabled real time
monitoring of trypsin activity in assay times that lasted less than 15 minutes. The
enzymatic assays could be performed at picomol trypsin levels. However, the assay
times increased with decreasing trypsin concentration.

The probes were used to

determine the inhibition efficiency of the three organic compounds 4-(2-Aminoethyl)
benzene-sulfonyl fluoride hydrochloride, 4-Amidinophenylmethane-sulfonyl fluoride
hydrochloride and 1, 10 phenanthroline. We also have successfully applied rhodaminelabeled peptide coated CdSe/ZnS quantum dots to monitor the proteolytic activity of
MMPs in normal and cancerous cell cultures. We were able to discriminate between a
normal and cancerous tissue in less than 15 minutes. The method can be extended to
other applications involving over expression of proteolytic activity. Changing the peptide
sequence would enable measuring the activity of specific proteolytic enzymes. It could
also enable high throughput screening of protease inhibitors and activators in an array
format. In their current form it was difficult to determine the inhibition efficiency of
larger trypsin inhibitors, for example protein molecules. It is possible that protein
molecules could displace the peptide molecules from the quantum dots. This would
release rhodamine molecules to the solution even in the absence of trypsin. To overcome
this difficulty, we are currently synthesizing CdSe/ZnS quantum dots that are capped with
the protein metalothionein (MT) following a method recently developed by Benson and
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coworkers (21). This would improve the stability of the quantum dots in biological media
due to MT binding to the quantum dots through multiple cystein residues. Additionally, it
would be possible to link rhodamine labeled to the MT capped quantum dots, which in
turn would result in more stable quantum dot FRET-based probes. The effect of MT
coating on the FRET efficiency and on the ability to monitor enzymatic cleavage of
peptide molecules using FFRET between the quantum dots and rhodamine residues
remained to be determined. We are also developing a lithographic technique to fabricate
quantum dot FRET-based arrays for high throughput screening of enzyme inhibitors and
activators.

62

3.5 References
1. Mandal, M., Mandal, A., Das, S., Chakarborti, T., Chakraborti, S., Molecular and
cellular biochemistry, 2003, 252; 305-329,
2. Kahari, V.M.; Saarialho-Kere, U., Ann Med., 1999, 31 (1), 34-45
3. Nawrocki, B., Ploette, M., Marchand, V., Monteau, M., Gillery, P., Tournier, J.M.,
Birembaut, P., Int. J. Cancer, 1997, 72, 556-564
4. Pham, W., Choi, Y., Weissleder, R., Tung, C. H., Bioconjugate Chem.. 2004, 15,
1403-1047,
5. Balduyck, M., Zerimech, F., Gouyer, V., Lemaire, R., Hemon, B., Grard, G.,
Thiebaut, C., Lemaire, V., Dacquembronne, E., Duhem, T., Lebrun, A., Dejonghe,
M.J., Huet, G., Clin. Exp. Metastasis, 2000, 18, 171-178
6. Ito, A., Nakajima, S., Sasaguri, Y., Br. J. Cancer , 1995, 71, 1039-1045
7. Nutt, J.E., Lunec, J., Eur. J. Cancer, 1996, 32A, 2127-2135
8. Ntziachristos, V., Tung, C.H., Bremer, C., Weissleder, R., Nature Med, 2002, 8, 757761
9. Weissleder, R., Ntziachristos, V., Nature Med, 2003, 9 (1), 123-128,
10. Bremer, C., Tung, C. H., Weissleder, R., Nature Med., 2001, 7, 743-748
11. Chang, E., Miller, J. S., Sun, J., Yu, W. W., Colvin, V. L., Drezek,R., West, J. L.,
Biochem Biophys Res Commun., 2005, 9; 334(4), 1317-1321
12. Medintz, I. L.; Clapp, A. R.;. Brunel, F. M.; Tiefenbrunn, T.; Uyeda, H. T.; Chang, E.
L.; Deschamps, J. R.; Dawson, P. E.; Mattoussi, H. Nat. Mater. 2006, 5(7), 581-589.
13. Clapp, A. R.; Medintz, I. L.; Mattoussi, H. ChemPhysChem 2006, 7 (1), 47-57.
14. Peng, Z. A.; Peng, X.; J. Am. Chem. Soc. 2001; 123(1); 183-184
15. Wang, D.; He, J.; Rosenzweig, N.; Rosenzweig, Z.; Nano Lett.; 2004; 4(3), 409-413.
16. Pinaud, F.; King, D.; Moore, H.P.; Weiss, S. J. Am. Chem. Soc. 2004, 126, 6115-6123
17. Rosenthal, S. J.; Tomlinson, I.; Adkins, E. M.; Schroeter, S.; Adams, S.; Swafford,
L.; McBride, J.; Wang, Y.; DeFelice, L. J.; Blakely, R. D.;J. Am. Chem. Soc. 2002,
124, 4586-4594.
18. Hahm, B.; Han, D.S.; Back, S.H.; Song, O.K.; Cho, M.J.; Kim, C.J.; Shimotohno, K.;
Jang, S.K.; J. Virol., 1995, 69, 2534-2539
19. Laura, R.; Robison, D.J.; Bing, D.H.; Biochemistry, 1980. 19, 4859-4864
20. Brannstrom, M.; Woessner Jr, J.F.; Koos, R.D,; Sear, C.H.; LeMaire, W.J.;
Endocrinology, 1988, 122, 1715-1721
21. Sandros, M. G.; Gao, D.; Benson, D. E. J. Am. Chem. Soc. 2005; 127, 12198-12199

63

CHAPTER 4 QUANTUM DOTS FRET BASED PH SENSOR

4.1 Introduction
A sensor that has the capability to measure cellular pH change can be used to probe
biological processes in cells. Measurement of pH in cells has indicated that there is a
difference between tumor and normal tissues (1-3). Water-soluble sensor systems capable
of detecting pH changes through fluorescence resonance energy transfer (FRET) between
organic dyes have been developed because of high sensitivity and high specificity for pH
variation in intracellular environments. Meanwhile, color change according to pH can be
monitored by microscopy. For example, Hong and coworkers designed a FRET based pH
sensor via a polymeric linker containing a sulfonamide group which undergoes the coilglobule transition at pH 7.0 and induces the distance change between pyrene (donor) and
coumarin 343 (acceptor)(4). Ohmichi and coworker reported a DNA-based pH sensor to
detect pH changed between pH 5.0-7.0 in living cells (5).
In recent years, the unique photophysical properties of luminescent quantum dots
make them more popular than organic dyes in imaging and sensing applications. The
luminescence of quantum dots is sensitive to the presence and characteristics of ligands
or molecules at surfaces or environments. Especially for quantum dots based sensors, it is
very important to understand what factors affect the optical properties of quantum dots.
Recently, some researchers have been working on studying pH effects on the
luminescence of quantum dot. For example, Tomasulo and coworkers demonstrated pH
induced transformations of chromogenic ligands on the surface of quantum dots, which
would activate the energy transfer from quantum dots to ligand and cause the quenching
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of

the fluorescence intensity of quantum dots (6, 7). Liu and coworkers use

mercaptoacetic acid capped CdSe/ZnSe/ZnS quantum dots as intracellular pH sensor in
SKOV-3 human ovarian cancer cells (8). They reported that quantum dots aggregated and
quenched in acidic environments. The fluorescence intensity of quantum dots increased
as the pH increased in both fixed and living cells. However, only a single color was found
that did not change effectively with the pH. Thus, more effective methods for monitoring
the pH change in biological media are needed. Here we take advantage of quantum dots
and FRET to investigate how pH affects quantum dots and show quantum dots FRET
based systems as a potential pH sensor in buffer solution.
Previous work with peptide RGDC coated quantum dots has shown small aggregate
quantum dots in PBS buffer at pH 7.4 due to the instability of disulfide bond between
quantum dots and peptide containing a single cysteine amino acid (9, 10). Benson and his
coworker have reported on cysteine-rich peptide MTs as capping ligands to improve the
stability of quantum dots via multiple thiol bonds (11, 12). MT is a collective name for a
superfamily of ubiquitous low molecular weight (6-7 kDa), cysteine-rich, metal-binding
proteins or polypeptides (13, 14). MT contains 61 or 62 amino acid residues, 20 of which
are cysteines which have high capacity of binding metal through sulfhydryl groups and
from metal-thiolate complexes (15). MT is also a lysine-rich peptide. The MT coated
quantum dots, full of amine groups on the surface of quantum dots for further
bioconjugation, were labeled with Rhodamine Red™-X succinimidyl ester through the
formation of amide bonds with ε -amine group of lysine in MT peptide to form the
quantum dots based FRET probes. FRET signal responded differently to pH values could
be monitored by the alternation on emission spectra and emission color of the probes.
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4.2 Experimental
4.2.1 Synthesis of mercaptohexadecanoic acid (MHDA)-coated quantum dots
MHDA coated quantum dots were prepared following a procedure for the synthesis of
lipoic acid capped CdSe/ZnS core-shell quantum dots developed by Bawendi (16), with a
slight modification. 25mg MHDA was heated up to 70-80°C until dissolved then 3mL ~
1μM TOPO-Qdots and 3mL chloroform was added and stirred for 2-3 hours at 50-60°C.
Then 6mL of H2O (containing tetramethylammonium hydroxide pentahydrate) was added
to the mixture and stirred for another half hour at room temperature after which it was
allowed to settle down for a few minutes. This resulted in a two-phase mixture with the
aqueous MHDA coated quantum dots layer above the organic chloroform layer. The
aqueous layer was collected and centrifuged several times to remove TOP/TOPO until
clear solution was observed. Then the clear suspensions were collected and spin dialyzed
2 times with a cutoff molecular weight of 30kDa to remove the excess MHDA. In each
spin dialysis cycle, the sample was centrifuged at 3000 rpm for 20 minutes and washed
with DI water. MHDA coated quantum dots were kept at 4°C in DI water until used.

4.2.2 Synthesis of Metallothionein (MT) coated quantum dots
MT coated quantum dots were prepared following the protocol development by
Benson and his coworkers (16). MHDA capped quantum dots were mixed with MT (the
mole ratio of MT/MHDA-quantum dots is 10) in DI water for 1 hour. Then the solutions
were spin-dialyzed to remove the unbound MT. In each spin dialysis cycle the sample
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was centrifuged at 3000 rpm for 20 minutes and washed with DI water. MT coated
quantum dots were kept at 4°C in DI water until used.

4.2.3 Conjugation of Rhodamine to MT coated quantum dots
Rhodamine labeled MT-coated quantum dots were prepared by adding 20µL of 0.30
MT coated quantum dots and varying volumes ranging from 0 µL to 80µL of 3.0
Rhodamine Red™-X, succinimidyl ester to a 20mM MOPS buffer solution at pH 6.5 to a
final volume of 1.0 mL. The reaction mixture was incubated for one hour at room
temperature, and then the spectra and image were measured under digital microscopy.
The spectra and images were taken through 40X objectives with numerical apertures of
0.9. A filter cube containing a 425 ±20 nm band-pass excitation filter, a 465 nm dichroic
mirror, and a 475nm long pass emission filter was used to ensure spectral purity. The
emission peaks of the quantum dot FRET probes were observed at 525 nm (quantum
dots) and 590 nm (rhodamine).

4.2.4 Effect of pH on the conjugation between Rhoamine and MT coated quantum
dots
20µL of 0.3µM MT coated quantum dots and 40µL of 3.0µM Rhodamine were added to
940µL of MOPS at different pH values (4.5, 5.5, 6.5, 7.5, 8.5, and 9.5) and incubated at
room temperature for half hour. FRET measurements were carried out by digital
microscopy and spectroscopy.
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4.2.5 Effect of pH on the FRET efficiency of Rhodamine labeled MT coated
quantum dots
200µL of 0.3µM MT coated quantum dots and 400µL of 3.0µM rhodamine were
added to 400µL of MOPS at pH 6.5 and incubated at room temperature for one hour.
Then 50µL of the quantum dots-MT-rhodamine conjugate was diluted with 450µL of
MOPS buffer at different pH values (4.5, 5.5, 6.5, 7.5, 8.5, and 9.5). Imaging and spectra
were taken at half hour, one hour, one and half hours, and two hours.
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Scheme 4.1 The synthesis of MT coated quantum dots
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4.3 Results and discussion
4.3.1. Effect of pH on the stability of MT coated quantum dots on buffer solution
Previous work with peptide RGDC coated quantum dots has shown small aggregate
quantum dots in PBS buffer at pH 7.4 due to the instability of the disulfide bond between
quantum dots and peptide containing a single cysteine amino acid (14, 15). Here we
utilize cysteine-rich-peptide MT as a capping ligand to improve the stability of quantum
dots. First, the TOPO coated quantum dots exchanged with MHDA to form the watersoluble quantum dots. Then MHDA coated quantum dots further exchanged with MT to
improve stability via multiple thiol bonds between cysteine in MT and quantum dots
(Scheme 4.1). MT is also a lysine-rich peptide. The MT coated quantum dots are
decorated with amine groups that are available for labeling with rhodamine succinimidyl
ester. As Figure 4.1 shows, the stability of MT coated quantum dots is dependent on pH.
At low pH, MT dissociates from the surface of quantum dots, which results in
aggregation and loss of solubility. At neutral or basic pH (≥6.5), the solitions are very
clear and there is no quantum dot aggregation. The solution can be stored over 1 month.
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Figure 4.1 Effect of pH on the emission images of MT coated quantum dots

4.3.2 Conjugation of Rhodamine to the MT coated quantum dots
Since MT coated quantum dots show high aqueous solubility at nearly neutral or
basic pH condition, the conjugation between MT coated quantum dots and rhodamine
were carried out in MOPS buffer at pH 6.5. Figure 4.2a shows the fluorescence spectra
of the quantum dot-MT-rhodamine conjugate at increasing ratio between the rhodamine
and quantum dots. The emission of the quantum dots at 525 nm decreased while the
emission of rhodamine at 590 nm increased with increasing rhodamine to quantum dots
ratio. This indicated the occurrence of FRET between the MT coated quantum dots and
the rhodamine molecules. The FRET efficiency increased with increasing rhodamine
concentration. Figure 4.2b depicts that the emission intensity of quantum dots decays as a
function of the rhodamine/quantum dots ratio. Here, Fd0 is the emission intensity of
unlabeled MT coated quantum dots and Fd is the emission intensity of rhodamine-labled
MT-coated-quantum dots. It was clearly shown that Fd/Fd0 decreases as the ratio of
rhodamine/quantum dots increases. For a 20:1 ratio of rhodamine to quantum dots, it
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indicates 70% quenching of quantum dots signal compared to unlabeled MT-coated
quantum dots.
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Figure 4.2 a) Emission spectra of rhodamine-labeled MT-coated quantum dots at
increasing the rhodamine to peptide coated quantum dots ratio: (a)0:1 (black),(b) 2:1
(red), (c)5:1 (green), (d)10:1 (dark blue), e)20:1 (light blue), f) 40:1 (pink); b) The
emission intensity of MT coated quantum dots decay percentage versus the ratio of
rhodamine and quantum dots in MOPS buffer at pH 6.5; Fd0 is the emission intensity of
quantum dots without labeling rhodamine and Fd is the emission intensity of quantum
dots in rhodamine-labled-quantum dots conjugate.
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Digital fluorescence images provide more visual evidence of FRET between the MT
coated quantum dots and the attached rhodamine. Figure 4.3 describes the images of
quantum dots-MT-rhodamine as a function of the rhodamine/quantum dots ratio. It can be
clearly seen that the emission color changes from green to orange progressively as the
ratio of rhodamine/quantum dots increases. The change of emission color also indicates
that there is FRET between MT coated quantum dots and rhodamine.

Figure 4.3 Digital fluorescence images of quantum dots-MT-Rhodamine at the different
ratio of rhodamine/quantum dots.

Figure 4.4 shows spectra and imagse of rhodamine-labeled MT-coated quantum dots
probes with a ratio of 20:1 of rhodamine to quantum dots. The fluorescence intensity of
MT-coated quantum dots decreases by 3.3 times when labeled with rhodamine, whereas
the fluorescence intensity of rhodamine increases by 5.1 times when bound to MT-coated
quantum dots. This is another indication that the large emission signal at 590 nm of
rhodamine conjugate is a result of FRET between the quantum dots and bound rhodamine
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molecules, and not due to self-excitation of rhodamine molecules. The emission color of
MT-coated quantum dots and rhodamine were green and dark red, respectively. Whereas
the emission color of rhodamine labeled MT coated quantum dots were orange. The
emission color change indicates that rhodamine bound to quantum dots and result in the
FRET occurrence between MT coated quantum dots and rhodamine. Later luminescent
quantum dots based pH probes were prepared under this ratio conditions.
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Figure 4.4 The emission spectra and fluorescence images of a) MT coated quantum dots,
b) rhodamine and c) rhodamine labeled MT coated quantum dots in MOPS buffer at pH
6.5 with the ratio 20:1 of rhodamine:quantum dots
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4.3.3 Effect of pH on the conjugation between Rhoamine and MT coated quantum
dots
First, we examined the effect of pH on the conjugation between rhodamine and MTcoated quantum dots. MT-coated quantum dots and rhodamine were mixed under
different pH MOPS buffer for 1hour. The image and spectra of MT-coated quantum dots
mixed with rhodamine at different pH are shown in figure 4.5a. At low pH, the emission
color of the mixture is yellowish-green. The quantum dots are aggregated and not
available for conjugating with rhodamine. The emission color turns to orange as the pH
increases to 6.5 and quantum dots are very clear with no aggregation. Then, the solution
tends to turn back to green as the pH increases to 9.5. The fluorescence intensity of
quantum dots decreases and the fluorescence intensity of rhodamine increases as pH
increases from 4.5 to 6.5, then the emission spectra of quantum dots and rhodamine tend
to recover its original spectra as the pH is raised from pH 6.5 to pH 9.5. The fluorescence
intensity ratio of MT-coated quantum dots to rhodamine is plotted against pH values, as
shown in figure 4.5b. Here, Fd is the fluorescence intensity of quantum dots at 525nm, Fa
is the fluorescence intensity of rhodamine at 590nm. It can be clearly seen that the
intensity ratio Fd/Fa decreases quickly from 1.5 to 0.3 as pH increase from 4.5 to 6.5 and
reach the minimum at pH 6.5, indicating the FRET from quantum dots to rhodamine
occurs. As the pH is raised from pH 6.5 to 9.5, the intensity ratio increases from 0.3 to
0.9 which indicating the FRET efficiency decrease.
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Figure 4.5 pH effect on conjugatioin between MT coated quantum dots and rhodamine.
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at different pH values; b) Plot of intensity the ratio of MT coated quantum dots (Fd) and
rhodamine (Fa) as a function of pH.

75

The above phenomena could be explained by the schematic model shown in scheme
4.2. At low pH, the amine terminus and ε-amine group of lysine in MT peptide will be
protonated and also MT probably dissociates from the surface of the quantum dots, which
results in the aggregation of quantum dots. Rhodamine will not be able to bind to the
surface of quantum dots and it remains far away from quantum dots in the solution, and
quantum dots will maintain their fluorescence and green emission color. At nearly
neutral and slight basic condition, the amino group is maintained in the non-protonated
form then amine-reactive rhodamine dye will react and the fluorescence intensity of
quantum dots will be quenched by rhodamine due to FRET. This results in the emission
color of quantum dots drastically changing from green to red as the pH increases.
However, at even higher pH, rhodamine succinimidyl ester hydrolysis could compete
with conjugation between rhodamine and MT-coated quantum dots, which would
decrease the FRET signal.
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Scheme 4.2 A schematic representation of the mechanism of signal response to the
change of pH
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4.3.4 Effect of pH on the FRET efficiency of rhodamine labeled MT coated quantum
dots
Here we further investigate the possibility of using rhodamine-labeled MT-coated
quantum dots system as pH sensor. Quantum dots FRET based pH probes were first
formed in MOPS buffer at pH 6.5 for half hour, and then diluted 10 times in MOPS
buffer at different pH values. The fluorescence intensity ratio (Fd/Fa) and image of
quantum dots FRET probes under different pH values were measured over time. The
fluorescence intensity ratio Fd/Fa is pH dependent and time dependent, as shown in figure
4.6a. First, as pH increases from 4.5 to 6.5, Fd/Fa decrease was observed. Then pH
continuity rises from 6.5 to 9.5, Fd/Fa increased. Fd/Fa increases over times and increase
faster in pH 4.5 and pH 9.5. Figure 4.6b shows the images of quantum dots probes under
different pH values over time. In acidic pH (4.5), the quantum dots aggregate over time
with emission color turning green. Likely, at low pH, MT dissociates from the surface of
quantum dots, which will cause the aggregation of quantum dots and rodamine far away
from quantum dots, resulting in low FRET efficiency. At pH 6.5, the quantum dots are
clear and orange emission color, which indicates the FRET occurred. At higher pH (9.5),
quantum dots turn green without aggregation. It is possible that the amide bond between
MT and rhodamine hydrolyzes over time and releases rhodamine from the surface of
quantum dots, which decreases FRET efficiency.
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4.4 Conclusions
A quantum dots FRET based pH sensor was synthesized via labeling MT coated
quantum dots with rhodamine. The stability of MT coated quantum dots is pH dependent
in MOPS buffer solution. Quantum dots aggregated at low pH. FRET efficiency was pH
dependent and time dependent, which could be confirmed by the fluorescence emission
spectra and images. The FRET signal between quantum dots and rhodamine responded to
pH changes. This was confirmed by emission spectra and images. FRET efficiency was
pH dependent and time dependent. The FRET efficiency reached maximum at pH 6.5 and
decreased either in lower or higher pH. MT dissociates from the surface of quantum dots
at low pH, which will cause aggregation and rhodamine would be far away from quantum
dots, which decreases FRET efficiency. The amide bond between MT and rhodamine
would hydrolyze over time at high pH, releasing rhodamine from the surface of quantum
dots, which results in low FRET efficiency. It is expected that this quantum dots FRET
based pH sensor could be used for investigating biological phenomena. Continued studies
will involve surface modification of quantum dots to improve their stability and
biocompatibility in the cellular environment. It is also important to design quantum dot
based sensors which specifically respond to pH changes in the cellular environment, but
are not affected by other factors, such as ionic species, temperature, and electric field.
Design method for effective intracellular delivery of quantum dots will be carried out.
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CHAPTER 5 REVERSIBLE QUANTUM DOTS BASED
IRON SENSOR

5.1 Introduction
Iron is associated with cell growth, cell division and cellular differentiation (1). In
biological systems the most of cell iron is protein bound; only a minor fraction is labile
iron (2). Cell damage associated with iron overload (IO) has been attributed to the
emergence of excessive levels of cell labile iron. The labile iron can catalyze the
formation of reactive oxygen species (ROS), such as hydroxyl radical (OH.) via Fenton
reaction. The highly reactive hydroxyl radical attacks lipid, proteins and DNA, which
result in DNA oxidation, mitochondrial damage, and the peroxidation of membrane lipids
(3, 4). Also, the excess labile iron can react with unsaturated lipids to form alkoxyl and
peroxyl radicals, which result in the impairment of cellular functions and lead to damage
of cells beyond the cellular defense capacities (5, 6). A major objective of researchers in
this area is to develop the method to detect the labile iron and understand the mechanisms
of chelator access routes to cellular sites of labile iron accumulation in model cells
relevant to IO and design drug for the treatment of IO disease (7). The detection and
quantification of labile iron in intracellular or extracellular compartments can be achieved
by physical or chemical methods. However, the physical method (AES, ICP) will destruct
the sample and chemical methods (ESR, colorimetric) are not sensitive and not easy
adaptable to high throughput assays. Fluorescence detection of iron is the most favorable
due to simplicity and sensitivity (8).
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Cabantchik is a world expert in the area of iron cellular biology and published
extensively in this area (9-16). Recent studies in the Cabantchik laboratory focused on
the design of fluorescent probes with iron chelation capability, which allow targeting
specific cell compartments and response to metal binding by signal change. These probes
change their emission properties upon binding to cellular iron. The Cabantchik research
group often uses H9C2 cardiomyocytes as a cell model. However, it is also important to
measure labile iron in brain tissue since abnormally high iron level was found in brain
tissue of Parkinson patients (17). The poor photostability of organic fluorophores
prevented long term cellular studies. The objective of the study is to design quantum dots
based cellular probes to labile iron in iron-rich astrocytes with increased photostability
over previously used organic fluorophore based probes.
Luminescent quantum dots have been a promising approach to fluorescent chemical
sensing and they have attracted great interest in recent years among biological researchers
since they provide solutions to problems associated with use of organic fluorophores in
cellular studies due their unique optical properties. The most important feature is their
photostability, which can be 100 times better than that of organic fluoreophores. Our
research group first demonstrated the development of quantum dots based ion probe for
Zn2+ and Cu2+ ions by CdS quantum dots capped with L-cysteine and triglycerol as
selective probes in aqueous media (18). Since then, different quantum dots based ion
probes have been devised over the past few years (19-27). For example, Leblanc and his
coworker reported the peptide (Gly-His-Leu-Leu-Cys)-coated CdS quantum dots for the
detection of Cu2+ and Ag+ in the micromolar level (19). CdSe functionalized with Lcysteine exhibited strong specific affinity for Hg2+ through quantum dots interface
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functional group were reported by Zhu’s research group (22). Sanz-Mendel and coworkers made an important contribution to introduce quantum dots into the area of
anionic detection (23, 24). Zhao and his coworker use mercaptoacetic acid coated CdS
quantum dots as fluorescence probes for sensitive and selective detection of highly
reactive HSe- ions in aqueous solutions (25). However, the mechanisms for the quenching
or enhancement of luminescence of quantum dots are still not clearly understood (28). In
some cases, the fluorescence change is due to electron transfer between Cd2+ and metal
ions (18). Chiu’s research group reported a fluorogenic sensor for K+ sensors in aqueous
solution based on 15-crown-5 functionalized CdSe/ZnS quantum dots via the Forster type
energy transfer between two different color quantum dots. The detection limit is around
uM. To a certain extent, the core/shell can avoid the electron transfer from CdSe core to
the metal ions (27). Cu+, Pb2+, Ag+ ions also can quench luminescence of quantum dots
by replacing the Cd2+ ions in the nanocrystals’ lattice (29). The quenching is permanent,
not easy reversible, and usually not analyte specific, which is not practical as a sensing
probe (30). CdSe is overcoated with ZnS shell to improve the stability, which will enable
the detection of target analytes to be reversible.
To our best knowledge, there is no report on reversible quantum dots based selective
iron ion sensing. If the response of quantum dots to ions is reversible, they can be used
for real-time monitoring fluctuations in iron concentration. Here, this chapter first reports
the development of reversible quantum dots based sensor for iron. A schematic diagram
of the quantum dot iron ion probes is shown in scheme 5.1. First, CdSe quantum dots
were overcoated with ZnS shell to improve the stability of CdSe core. To fabricate the
quantum dot-based iron probes, they were functionalized with metallothionein (MT).
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Then the surface of the MT coated quantum dots was modified with EDTA. EDTA was
selected as a capping ligand because of relatively low binding affinity (mM level) to iron
ions. When captured by the EDTA molecules, iron ions quenched the emission intensity
of the quantum dots. Removal of iron from the quantum dot surface by free EDTA or
other iron chelators with higher binding affinity resulted in a rise in the quantum dots’
luminescence. The analytical properties of the probes including sensitivity, selectivity,
and reversibility were characterized.

EDTA (relatively lower binding affinity and specificity)
Iron
Iron chelators (highly specific iron chelators)

Scheme 5.1 Schematic representation of reversible quantum dots based iron sensor.
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5.2 Experimental
5.2.1 Synthesis of EDTA coated quantum dots
Excess amount of glutaraldehyde was added to MT capped quantum dots in MOPS
7.0 buffer for 1-2 hours at room temperature with continuous mixing, then spin dialysis to
remove the unbound glutaraldehyde. An excess amount of aminobenzyl-EDTA was
added to the above resulting solution and incubated for 2-4 hours at room temperature
with continuous stirring, which followed by spin dialysis to remove excess aminobenzylEDTA. The bond formed between an amino group and an aldehyde from a reversible
Schiff base is not stable and it must be reduced by a process called reductive alkylation in
order for the bond to be covalent. Sodium cyanoborohydride was added the above
solution and mixed gently for 30 minutes. The product was spin dialyzed and
resuspended in MOPS 7.0 buffer to a desired storage concentration, then stored at 4°C
until used.

5.2.2 Iron response
200 µL of 30nM EDTA capped quantum dots and 200μL of varying concentration
iron ranging from 1µM to 1mM were added to MOPS buffer solution at pH 7.0 to a final
volume 1.0 mL. Response time measurements were carried out following the addition of
iron using a fluorescence spectrometer. Emission spectra were recorded 3 minutes after
adding iron solution (λex =400nm).
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5.2.3 Selectivity
The EDTA capped quantum dots were tested for their response to other biologically
relevant ions such as Na+, K+, Ca2+, Mg2+, Mn2+, and Cu2+. 200 µL 30nM EDTA capped
quantum dots and 200μL of 1mM cations were added to MOPS buffer solution at pH 7.0
to a final volume 1.0 mL. Emission spectra were recorded 3 minutes following adding
iron solution (λex =400nm).

5.2.4 Reversibility
Reversibility was measured by monitoring the change in fluorescence intensity upon
the addition of iron chelator to the solution of EDTA capped quantum dots with iron
suspended in a MOPS buffer solution at pH 7.0. The fluorescence intensity was measured
as a function of time using excitation wavelength of 400nm and an emission wavelength
of 605nm. To conduct the measurement, 200μL 30nM EDTA capped quantum dots in
600μL MOPS buffer solution at pH 7.0 was placed in the fluorometer and the emission
was monitored. Then, 200μL of 1mM iron solution was injected into the cuvette until the
signal reached saturation, and 100μL of 50mM iron chelators were injected to the above
solution. The emission measurement was continuously carried out to monitor the
reversibility.
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Scheme 5.2 The synthesis of quantum dots based iron sensor
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5.3 Results and discussion
5.3.1 Effect of capped ligands on the Fluorescence of quantum dots
The synthesis of quantum dots iron probes was described in the experimental section.
MT is also a lysine-rich peptide. The MT coated quantum dots, full of amine groups on
the surface of quantum dots, conjugated with aminobenzyl-EDTA via glutaraldehyde to
form the quantum dots iron probes (EDTA coated quantum dots) (see scheme 5.2 ). The
normalized emission spectra of quantum dots capped with TOPO, MHDA, MT and
EDTA are shown in figure 5.1 (excitation at 400nm). All samples were excited at 400nm
Emission scans measured from 480nm to 700nm. It can be clearly seen in figure 5.1a
that emission intensity of the MHDA coated quantum dots was 3 times lower than the
emission intensity of TOPO coated quantum dots. Figure 5.1b showed that MT as
capped ligands would increase 20% of the emission intensity of quantum dots. Whereas,
the EDTA as capped ligands would decrease the emission intensity of quantum dots by
50% (figure 5.1c). These results showed that the surface ligands have intense effects on
fluorescence emission of quantum dots. Surface chemistry would affect the photophysical
properties of quantum dots. This is very crucial for development of quantum dots based
probes. More research work need to done to form fully stable water-soluble quantum
dots.
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Figure 5.1 Effect of capped ligands on the fluorescence intensity of quantum dots
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5.3.2 Iron response
First, we measured the response time of EDTA capped quantum dots to Fe2+ in
MOPS buffer solutions at pH 7.0 (figure 5. 2). Here, F0 is fluorescence intensity of the
EDTA capped quantum dots in an iron free solution and F is fluorescence intensity of
EDTA capped quantum dots following adding iron ion. It can be clearly seen that Fe2+ in
the form of ferrous ammonium sulfate added to EDTA coated quantum dots in ambient
conditions evoked a rapid and robust quench of the fluorescence intensity of quantum
dots. As reported by the Cabanchik research group, Fe2+ rapidly oxidized to Fe3+ when
Fe2+ was bound to EDTA (8).

Add iron
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Figure 5.2 Characterization of the response time of the quantum dots iron sensor- the
fluorescence intensity of the EDTA coated quantum dots prior and following the injection
of an aliquot of concentrated Fe2+ solution (ferrous ammonium sulfate) is shown.
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The iron concentration dependence of the fluorescence intensity of EDTA capped
quantum dots is shown in figure 5.3a. It can be clearly seen that the fluorescence intensity
of EDTA capped quantum dots decreases with the increasing Fe2+ concentration. We
found that the quenching effect of iron on the fluorescence emission of EDTA capped
quantum dots could be best described by a Stern-Volmer-type equation [5]:

Fmax
= 1 + K sv [Q]
F

[5]

F and Fmax are the fluorescence intensities of the EDTA capped quantum dots at a given
iron concentration and in an iron free solution. Q is the iron concentration. Figure 5.3b
showed a Stern-Volmer quenching curve describing Fmax/F as a function of iron
concentration. The Stern-Volmer quenching constant, Ksv , was determined to be 6710 M1

. A good linear relationship (r > 0.993) was observed up to iron concentrations ranging

from 0 to 200 μM, which allows the development of a method for the detection of iron.
However, converse to typical Stern-Volmer quenching behavior, which is driven by
collisions between quenchers and luminescent molecules, the quench of luminescence of
EDTA capped quantum dots is attributed to iron binding followed by a charge transfer
process on the surface of quantum dots. The experimental data can be explained in terms
of the strong affinity of iron with EDTA, the surface ligands of quantum dots.
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Figure 5.3 Effect of Fe2+ ion concentration on the emission of EDTA capped quantum
dots. a) Fluorescence emission spectra; b) A stern-Volmer plot effectively describes the
iron concentration dependence of the luminescence intensity of EDTA capped quantum
dots with a Stern-Volmer constant Ksv=6710 M-1.
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We observed that there was a rapid and intense quenching on fluorescence of
quantum dots between Fe2+ and EDTA coated quantum dots. On the other hand, we also
observed that Fe3+ in the form of ferric chloride only evoked a slower and lower
quenching on fluorescence of quantum dots in figure 5. 4. This result is probably due to
the poor solubility of FeCl3. Even with quantum dots based probes, these results also
agreed with that of fluorophore from Cabanchik’s research group (8). They have already
extensively discussed that the rate and extent of Fe2+ and Fe3+ binding to the probes in
ambient conditions is associated with the solubility and stability constant of the ironanion salt complex and the capacity of the chelator to shift the oxidation state of the metal
to that of higher affinity to a certain extent.
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Figure 5.4 Effect of Fe3+ ion concentration on the emission of EDTA capped quantum
dots.
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Digital fluorescence images are shown in figure 5 and they show clear visual
evidence of the effect of iron on fluorescence of EDTA capped quantum dots. It can be
seen that the emission color of the quantum dots in iron free solution is red (emission
wavelength 605nm). It should be mentioned that there is no aggregation on EDTA
capped quantum dots. These results suggested that using cysteine-rich peptide MT as
capped ligands improves the stability of quantum dots via multiple thiol bonds. The
emission color of quantum dots get darker with the increasing iron concentration. This
result suggests that iron quenches the fluorescence emission of EDTA capped quantum
dots.

[Fe2+]=0µm

20µm

100µm

200µm

Figure 5.5 Digital fluorescence images of EDTA capped quantum dots with increasing
concentration of iron, the images were taken through 40X objectives with numerical
apertures of 0.9.
.
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To further understand the mechanism of the quenching effect of iron on EDTA
capped quantum dots, first control measurements that involved iron effect on MT capped
quantum dots were carried out. Figure 5.6 describes the normalized fluorescence spectra
of quantum dots with 200 μM iron level. Figure 5.6a shows that the fluorescence
intensity of EDTA capped quantum dots decreases by 60% when exposed to 200 μM
iron. However, Figure 5.6b reveals that this iron level hardly affects the fluorescence
emission of the MT capped quantum dots. These results indicated that the quenching
effect of iron on EDTA capped quantum dots is due to the specific binding between iron
and EDTA molecules on the surface of quantum dots and not due to non-specific
adsorption on the surface of quantum dots.
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Figure 5.6 Normalized Fluorescence spectra of a) EDTA capped quantum dots and b)
MT capped quantum dots with 200μM iron solution
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Since Fe2+ rapidly oxidizes to Fe3+ when Fe2+ binds to EDTA, one should also be
aware of inter filter effects of Fe3+ that may quench the fluorescence of quantum dots.
Additionally, we further study whether inner filter resulting from the strong absorption of
the excitation wavelength by iron is the factor of the quenching effect of iron on the
luminescence of EDTA coated quantum dots. Since Fe2+ rapidly oxidizes to Fe3+ when
Fe2+ binds to EDTA, Fe3+ would react with fluoride ion to form the colorless complex
FeF6 and eliminate the inner filter effect (18). Figure 5.7 shows the emission of EDTAquantum dots complex did not change in the presence of 200 mM of F ions. It is still
quenched by iron ions. This result suggests that the quenching effect of Fe2+ on
luminescence of EDTA coated quantum dots is not due to an inner filter.
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Figure 5.7 The emission of EDTA coated quantum dots with 200mM fluoride ion ([iron]
=200μM)
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5.3.3 Selectivity
The above result shows that the fluorescence emission of quantum dots is quenched
by 60% in a solution containing 200μM iron. To better understand selectivity of EDTA
capped quantum dots towards iron, we compared the iron response with other
biologically relevant ionic species. The response of EDTA capped quantum dots to
biologically relevant ions such as Na+, K+, Ca2+, Mg2+, Mn2+, Cu2+ is shown in figure 5.8.
The fluorescence intensity of quantum dots decreased by 20% to Na+, K+, Ca2+, Mg2+,
and Mn2+. Iron and copper ions quench the fluorescence emission of quantum dots by
60% and 90% respectively. The mechanism of cupper ions quenching the luminescence
of EDTA coated quantum dots is not fully understood, probably due to the non-specific
binding. However, the copper would not be a potential interference since these probes
will be carried out in the iron rich cell culture.
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Figure 5.8 Effect of 200uM biologically relevant ions on the fluorescence emission of
EDTA capped quantum dots.
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5.3.4 Reversibility
The largest challenge of this project is the reversibility of quantum dots based iron
sensor. Here two different iron chelators were used to carry out the reversibility of
quantum dots iron sensor. 3-hydroxy-1,2-dimethyl-4(1H)-pyridone (HPO) comprised
highly specific iron chelators. HPO is a bidentate chelator, which means three molecules
can coordinate on Fe3+ in free solution (31). EDTA has relatively lower metal-binding
affinity and specificity. The reversibility of quantum dots based iron sensors is depicted
in figure 5.9. Temporal dependence measurement was carried out to provide the dynamic
information. First, Fe2+ solutions were added into the EDTA coated quantum dots. As
expected, a decrease in fluorescence intensity was observed. Then, the chelators were
added to the above solution, the fluorescence intensity of quantum dots was increased
over time. These results suggested that the chelator remove iron from the surface of
quantum dots and de-quenched the fluorescence intensity of quantum dots. HPO shows
higher recovery ability than EDTA due to the higher binding affinity. The recovery of
quantum dots intensity by HPO and EDTA is 35% and 17% respectively in the level of
4.55 mM. This clearly demonstrated the reversibility of quantum dots based iron sensor.
However, the quenching of EDTA coated quantum dots by iron can not be fully
recovered with chelator EDTA or HPO. It is possible there is also some non-specific
binding of iron on surface of quantum dots, which can’t be removed by the EDTA or iron
chelator.
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Figure 5.9 Reversibility of quantum dots based probes. Temporal dependence of EDTA
coated quantum dots in the presence of the tested chelator. Fluorescence of EDTA coated
quantum dots is quenched by Fe2+, and reversed by adding the chelator EDTA and HPO

As we have observed, Cu2+ also quenched the fluorescence intensity of EDTA coated
quantum dots. Actually Cu2+ showed a higher quenching activity compared with Fe2+.
Here, we also measured the reversibility of quantum dots based probes in the presence of
Cu2+ (figure 5.10). The fluorescence intensity of quantum dots is quenched by 90% with
200uM Cu2+. However, the fluorescence is not recovered by the chelator EDTA or HPO.
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These results indicated that Cu2+ quench the fluorescence intensity of EDTA coated
quantum dots is due to non-specific adsorption, and not due to the binding affinity
between Cu2+ and EDTA on the surface of quantum dots.
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Figure 5.10 Temporal dependence of EDTA coated quantum dots in the presence of Cu2+
and tested chelator. Fluorescence of EDTA coated quantum dots is quenched by Cu2+,
and not reversed by adding the chelator EDTA and HPO.
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5.4 Conclusions
Luminescent quantum dots have been a new approach to fluorescence sensing since
they provide solutions to problems associated with use of organic fluorophores in cellular
studies due their unique optical properties. Here, we describe for the first time the
development of a reversible quantum dots based iron sensor. We have successfully
synthesized and designed quantum dots based iron sensors. The effect of different capped
ligand on the fluorescence intensity of quantum dots was investigated. MT as capped
ligand of quantum dots could improve the stability of quantum dots through the multiple
thiol bonds. MT capped quantum dots conjugated with aminobenzyl-EDTA to form the
EDTA coated quantum dots, quantum dots based iron probes. However, the surface
ligands have intense effects on fluorescence emission of quantum dots. It is very
important to form the fully stable quantum dots, especially for quantum dots based
sensors. The quantum dots probes show high sensitivity towards iron ions. A SternVolmer equation can best describe the iron concentration dependence of the quenching of
fluorescence intensity of quantum dots. The insensitivity of MT coated quantum dots to
iron ions indicates that the quenching mechanism is the binding affinity between iron and
EDTA on the surface of quantum dots. Since Fe2+ rapidly oxidizes to Fe3+ when Fe2+
binds to EDTA, one should also be aware of inter filter effects of Fe3+ that may quench
the fluorescence of quantum dots. By adding F- ions to the quantum dots iron complex,
the fluorescence intensity of quantum dots didn’t recover, which indicates that the inner
filter effect is not the reason for quenching. The selectivity of quantum dots based probes
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is not perfect. Cu2+ show a higher quenching effect on the fluorescence of quantum dots
than iron at 200 uM. Later, we found out that the quenching is due to non-specific
adsorption, not specific binding affinity between Cu2+ and EDTA on the surface of
quantum dots. Since these probes will be carried out in the iron rich cell culture, the Cu2+
will not be a potential interfering agent. The reversibility of quantum dots iron sensors
also was investigated. Iron chelators remove iron from the surface of quantum dots,
which results in the increase of the previously quenched fluorescence of quantum dots. 3hydroxy-1,2-dimethyl-4(1H)-pyridone (HPO) showed a higher a recovery ability of
fluorescence intensity of quantum dots than EDTA. However, neither of them shows a
full florescence recovery. We are now using higher specificity iron chelator to monitor
the reversibility of quantum dots probes. Furthermore, reducing the non-specific binding
and improving the selectivity have to be done before carrying out these probe for
intracellular assays of labile iron in iron enriched astrocytes.
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CHAPTER 6 SUMMARY AND CONCLUSIONS

Fluorescence, combined with digital microscopy and fluorescence resonance energy
transfer (FRET), has been a very sensitive and powerful method for monitoring biological
events. Molecule sensors able to monitor environmental changes, such as concentration
of enzyme, pH, ionic species, etc, have been sought for probing biological phenomena in
cells. CdSe/ZnS core/shell quantum dots have attracted great interest and emerged as a
novel type of fluorescent probes in many biological and biomedical fields. They show
unique photophysical properties, such as narrow and symmetrical emission spectra, broad
absorption spectra, high quantum yield, high chemical stability, high photostability, and
size dependent luminescence. In this Ph.D study, luminescent quantum dots based
sensors have been developed for protease measurement, pH measurement and iron
measurement.

In recent years, several studies have demonstrated the use of luminescent quantum
dots as donors to detect biomolecules, such as DNA, RNA, protein, enzyme, etc. Chapter
3 describes, for the first time, the development of quantum dot FRET-based enzymatic
activity probes and their use for the measurement of extracellular matrix
metalloproteinases (MMPs) activity in normal and cancerous breast cell cultures. The
methodology proposed in Chapter 3 is advantageous since it enables real-time monitoring
of the proteolytic activity of MMPs and the measurement takes only 15 minutes to
complete in both aqueous solution and cell culture. The use of molecular fluorophores as
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acceptors enabled a ratiometric measurement technique to monitor FRET changes. This
results in simultaneous changes in the quantum dots and fluorescent acceptors emission
peaks. The high photostability of quantum dots enables long observation times that are
required to monitor proteolytic activity. Chapter 3 discusses the fabrication,
characterization, and applications of novel luminescent quantum dots FRET based
protease activity probes.

The luminescent probes are based on FRET between

luminescent quantum dots that serve as donors and rhodamine acceptors that are
immobilized to the surface of the quantum dots through peptide linkers that contain
selective enzymatic cleavage sites. First the probes were used to test the enzymatic
activity of trypsin in solution. The FRET signal changes were found to be dependent on
trypsin concentration and time. The enzymatic assay was completed rapidly (less than 15
minutes). Meanwhile, the probes were capable of determining the different inhibition
efficiency of three organic trypsin inhibitors, 4-(2-aminoethyl) benzene-sulfonyl fluoride
hydrochloride, 4-amidinophenylmethane-sulfonyl fluoride hydrochloride and 1, 10
phenanthroline. In the experiments, we found out that it was difficult to determine the
inhibition efficiency of larger protein trypsin inhibitors. It is possible that the bond
between quantum dots and peptides is not very strong, and that protein molecules could
displace the peptide-rhodamine from the surface of quantum dots and would result in
FRET signal change even in the absence of trypsin. Using the probes we were able to
discriminate between normal and cancerous cells in less than 15mins primarily due to the
difference in the proteolytic activity of their extracellular matrices. To improve the
stability of the quantum dots in biological media is very important to develop quantum
dots based biosensor. For example, metallothionein will be used as an improved capping
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ligand since it binds to the quantum dots through multiple cysteine residues. The novelty
in this method is in the use of quantum dots as dynamic probes rather than imaging
contrast agents. Another novel aspect of the study is the flexibility of the approach. While
the current peptide linker enables discrimination between normal and cancer breast cells,
modification of the peptide sequence will enable use of these probes to monitor other
biological systems that are characterized by overexpression of proteolytic enzymes.
Furthermore, the probes could also be used to screen for the efficiency of protease
activators.

Change on pH is very important for the biological process. Taking advantage of
unique properties of quantum dots and the high sensitivity of FRET, Chapter 4
demonstrates the development of quantum dots FRET based sensor for pH measurement.
The FRET probes were synthesized by labeling MT coated quantum dots with
rhodamine. The novelty of this probe is the FRET signal between quantum dots and
rhodamine responded differently to pH in the wide range from 4.5 to 9.5. Another novel
aspect is that the pH response could be monitored not only by the alteration on emission
spectra, but also by the change on images. MT was used as the capping ligand to improve
the stability of quantum dots. However, the digital fluorescence images show that the MT
coated quantum dots are not stable and they aggregated at low pH. The MT coated
quantum dots were very stable when pH >=6.5 and they can be stored over 1month in
MOPS buffer. FRET efficiency was pH dependent and time dependent. The FRET
efficiency achieves the maximum at pH 6.5 and decreases either in lower or higher pH.
We expect that this quantum dots FRET based pH sensor could be used for investigating
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biological process. This is an active research area to use quantum dots as fluorescence
probes to monitor intracellular pH. Although some research groups, including us, have
achieved some success on the process, there is still more research work necessary. The
first thing is the surface modification of quantum dots to improve the stability and
biocompatibility in cellular environment. The most important thing is to design the
quantum dots based intracellular sensors which only specifically respond to protons (pH)
in cellular environment, but are not affected by other factors, such as ionic species,
temperature, and electric field.

In our laboratory, we have developed quantum dots based ion sensors by capping CdS
quantum dots with thioglycerol, cysteine and polyphosphate. The luminescence of
quantum dots responds differently to metal ions. However, the quench of luminescence of
quantum dots by ions is permanent, so this sensor was not reversible. For the first time,
chapter 5 demonstrates the development of a reversible quantum dots based iron sensor.
The quantum dots were capped with EDTA and the fluorescence of quantum dots was
quenched by iron. Iron chelators in solution removed iron from the surface of quantum
dots, which resulted in the increase of the previously quenched fluorescence of quantum
dots. In the experiments, we found out that the surface capping ligands could affect the
fluorescence emission of quantum dots, which indicates that the surface chemistry would
change the photophysical properties of quantum dots. The iron concentration dependence
on the quench of quantum dots fluorescence intensity can be described by the SternVolmer equation. The control experiments showed that the fluorescence intensity of MT
coated quantum dots was not affected by the same level of iron ions, which indicates that
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the quench mechanism is probably the binding affinity between iron and EDTA on the
surface of quantum dots. Moreover, the fluorescence intensity of quantum dots iron
complex didn’t change on the presence of F- ions, which indicates that the inner filter
effect is not the reason of quenching. However, the mechanism of the quench on
luminescence of quantum dots by iron is not fully understood. More experiments are
needed to be done to fully understand the quenching phenomenon. Copper ions also
showed a quenching effect on the fluorescence of quantum dots 200 uM level. However,
the quench on fluorescence intensity could not be recovered by EDTA, which suggested
that the quenching by copper is possible not due to non-specific binding affinity between
copper and EDTA on the surface of quantum dots. However, the copper would not be a
potential interference since these probes will be carried out in the iron rich cell culture.
The novelty of this quantum dots based iron sensor is the reversibility. The reversibility
of quantum dots iron sensors also was investigated by adding the EDTA or iron chelator
3-hydroxy-1,2-dimethyl-4(1H)-pyridone(HPO). In the level of 4.45mM, the fluorescence
intensity of quantum dots was recovered 35% by HPO, and only 17% by EDTA.
However, either EDTA or HPO showed a full florescence recovery. It is possible there is
also some non-specific binding of iron on surface of quantum dots, which can’t be
removed by the EDTA or iron chelator. Before applying these sensors for intracellular
assays of labile iron in iron enriched astrocytes, the selectivity and specificity of the
sensor need to be improved

Quantum dots have the advantages as fluorescence probes over organic dyes.
However, quantum dot have their limitations in biological application. Surface
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modification on quantum dots to impart the aqueous solubility and functional groups for
bioconjugation usually would decrease the quantum yield of quantum dots. Also quantum
dots have limited pH stability and tend to aggregate in biological media. Meanwhile
quantum dots have large surface-to-volume ratio, which allow a large number of
biomolecules able to be conjugated to the surface of a quantum dot. However, it is hard to
quantify the number of biomolecules conjugated on the surface of quantum dot.
Nonspecific binding or adsorption of small molecules on the surface of quantum dots also
was observed. Another concern is about cytotoxicity of quantum dots in experiments on
living cell or animal since cadmium and selenium are known to be toxic. All these
problems still need to be solved. Therefore, in the future, it is very important to modify
quantum dots to make them less toxic, more stable, biocompatible, and more efficiently
delivered/targeted into cells while remaining their optical properties intact.

112

VITA

The author was born in Fujian, China. She obtained her Bachelor’s degree and M.S.
degree in chemistry from Xiamen University in 1999 and 2002. To pursue higher
education, in 2003 she came to the chemistry department at the University of New
Orleans and became a member of Professor Zeev Rosenzweig’s research group.

113

